Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3022756	s-kerulo	mg/l (mg/l)	1783	1882	0.00%
3022756	s-kerulo	g/l (mg/l)	1123	1181	0.00%
3022756	s-kerulo	— (—)	350	383	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal findings on examination of blood, without diagnosis

627

1060

5.67

321.10

1.1

293.38

283.44

mg/l

2.03

575

945

Fibrosis and cirrhosis of liver

399

49.00

307.65

1.1

1.0

290.57

293.53

mg/l

0.13

352

Cirrhosis of liver, NAS

305

46.55

307.65

1.1

1.0

283.01

292.97

mg/l

0.50

272

Abnormal serum enzyme levels

491

662

7.57

307.65

1.1

293.73

281.45

mg/l

2.16

458

590

Alcoholic liver disease

323

128

27.45

307.65

1.1

1.0

285.34

283.09

mg/l

0.11

286

117

Nonalcoholic fatty liver disease

505

241

24.16

307.65

1.1

1.0

285.94

290.22

mg/l

0.31

436

218

Diseases of liver

1421

526

29.62

307.65

1.1

1.0

292.18

284.21

mg/l

1.48

1242

484

Other diseases of liver

763

279

30.32

307.65

1.1

1.0

292.78

289.31

mg/l

0.27

655

259

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

589

262

24.96

307.65

1.1

1.0

287.43

280.95

mg/l

0.60

525

235

Chronic hepatitis, not elsewhere classified

148

38.88

237.85

1.1

1.0

281.57

309.26

mg/l

1.22

129

Oesophageal varices

177

21.30

229.06

1.1

1.0

281.22

285.22

mg/l

0.14

163

Any gastric operation

759

910

4.23

219.94

1.1

285.77

612.27

mg/l

0.51

681

827

GASTRO-related operations

759

910

4.23

219.94

1.1

285.77

612.27

mg/l

0.51

681

827

Ascites

184

131

14.97

203.71

1.1

1.0

297.04

289.11

mg/l

0.38

162

115

Gastrointestinal diseases

538

544

5.00

187.20

1.1

286.71

812.44

mg/l

0.50

490

510

Other inflammatory liver diseases

154

16.66

180.95

1.1

1.0

299.98

289.99

mg/l

0.52

144

Hepatic failure, not elsewhere classified

112

29.09

165.50

1.1

1.0

293.49

295.00

mg/l

0.03

105

Alcohol use disorder, Swedish definition

549

1478

3.49

153.13

1.1

283.94

284.41

mg/l

0.04

488

1335

565

1573

3.34

146.55

1.1

284.26

284.08

mg/l

0.02

502

1422

576

1636

3.19

137.99

1.1

284.34

284.91

mg/l

0.06

512

1478

Anaemias

265

298

6.00

125.78

1.1

1.0

297.55

281.98

mg/l

1.70

238

279

Diseases of oesophagus, stomach and duodenum

850

2062

2.52

119.96

1.1

286.20

434.19

mg/l

0.53

752

1873

Abnormal results of function studies

167

227

7.68

116.55

1.2

1.0

295.73

286.37

mg/l

0.60

130

202

Autoimmune diseases excluding thyroid diseases

816

1863

2.45

105.54

1.1

292.49

444.00

mg/l

0.47

738

1686

Autoimmune diseases excluding thyroid diseases, strict definition

796

1817

2.46

103.98

1.1

292.23

447.88

mg/l

0.47

720

1643

Extrapyramidal and movement disorders

325

876

3.76

103.53

1.1

282.48

291.62

mg/l

1.39

294

779

Endocrine, nutritional and metabolic diseases

672

1304

2.64

98.29

1.1

284.74

512.49

mg/l

0.52

602

1200

Autoimmune diseases related-to ILD

668

2422

2.44

96.98

1.1

294.80

411.24

mg/l

0.47

604

2172

Primary biliary cholangitis (PBC)

21.63

95.92

1.1

328.16

297.23

mg/l

1.50

Autoimmune diseases

843

1874

2.31

94.18

1.1

288.18

443.23

mg/l

0.49

757

1697

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

726

2218

2.36

93.40

1.1

299.28

422.08

mg/l

0.45

649

1999

Type 2 diabetes, wide definition

573

1430

2.63

89.94

1.1

1.0

291.12

497.35

mg/l

0.50

496

1291

Used for control exclusion in common control thyroid runs

795

1752

2.31

88.93

1.1

287.49

453.65

mg/l

0.49

716

1583

ILD medications

845

2136

2.18

84.74

1.1

291.02

427.63

mg/l

0.49

767

1912

Disorders of gallbladder, biliary tract and pancreas

709

1989

2.31

84.74

1.1

293.02

440.07

mg/l

0.49

635

1784

Inflammatory bowel disease treatment related agents

848

2237

2.17

84.14

1.1

292.38

421.42

mg/l

0.48

774

2001

Medical observation and evaluation for suspected diseases and conditions

517

959

2.78

83.43

1.1

280.57

286.50

mg/l

0.90

460

870

Examination and observation for other reasons

449

955

2.88

81.58

1.1

297.92

286.70

mg/l

1.73

416

866

Type 2 diabetes

712

1866

2.28

80.71

1.1

287.98

451.04

mg/l

0.52

632

1685

Substance abuse, excluding more controls

442

1439

2.71

79.32

1.1

288.06

286.36

mg/l

0.17

387

1305

Anxiety disorders, excluding more controls

624

1775

2.35

77.73

1.1

293.99

290.80

mg/l

0.44

555

1606

First line medication for Crohn's disease

814

2092

2.13

77.11

1.1

289.55

431.48

mg/l

0.50

739

1869

Symptoms and signs involving the digestive system and abdomen

732

1637

2.25

77.00

1.1

285.11

288.27

mg/l

0.47

659

1486

Diabetes, varying definitions

736

2014

2.20

76.66

1.1

289.07

437.43

mg/l

0.51

652

1823

Diabetes mellitus

737

2024

2.19

75.85

1.1

289.26

436.85

mg/l

0.51

654

1830

ILD medications: prednisolone, methylprednisolone, prednisone

785

2095

2.13

74.67

1.1

289.51

430.54

mg/l

0.49

710

1874

Metabolic disorders

675

1897

2.22

73.19

1.1

293.03

445.00

mg/l

0.48

608

1709

Cholangitis (primary sclerosing, PSC)

126

8.15

73.11

1.1

1.0

306.96

291.76

mg/l

0.71

108

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

679

1879

2.22

73.01

1.1

287.02

447.64

mg/l

0.52

604

1700

Any reimbursement code in KELA

476

887

2.71

72.79

1.1

288.00

287.67

mg/l

0.02

435

799

Type 2 diabetes, definitions combined

656

1748

2.25

72.57

1.1

284.30

461.73

mg/l

0.53

581

1579

Type 2 diabetes, strict (exclude DM1)

657

1762

2.24

71.68

1.1

284.18

460.20

mg/l

0.53

583

1591

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

443

1620

2.55

71.61

1.1

1.0

295.56

289.95

mg/l

0.82

387

1445

Type 2 diabetes, definitions combined, including avohilmo

660

1759

2.23

71.47

1.1

284.75

460.56

mg/l

0.53

585

1591

Mood disorders, excluding more controls

669

1860

2.20

70.47

1.1

735.17

291.35

mg/l

0.50

597

1684

Glucagon-like peptide-1 (GLP-1) analogues

369

1085

2.82

70.47

1.1

282.76

288.72

mg/l

0.75

322

971

General symptoms and signs

794

1915

2.09

69.67

1.1

288.57

444.28

mg/l

0.50

728

1708

Diabetes medication

718

2068

2.12

69.11

1.1

289.44

433.77

mg/l

0.51

637

1866

ILD medications: immunosuppressive drugs

468

1870

2.42

67.86

1.1

292.89

446.30

mg/l

0.48

432

1681

Diabetes, insulin treatment (Kela reimbursement)

697

2017

2.13

67.51

1.1

287.65

437.50

mg/l

0.51

621

1814

Other (not insulin) diabetes medications

654

1827

2.17

66.46

1.1

284.64

454.36

mg/l

0.53

579

1646

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

279

394

3.57

66.20

1.1

286.99

288.29

mg/l

0.08

255

360

Heart failure, not strict

499

1464

2.37

64.09

1.1

303.56

487.62

mg/l

0.44

443

1303

Tramadol

565

1620

2.26

64.04

1.1

295.38

473.83

mg/l

0.48

502

1457

Condition for Implicit Sepsis (Organ dysfunction codes)

571

1884

2.22

63.85

1.1

292.01

445.58

mg/l

0.48

513

1680

Neurotic, stress-related and somatoform disorders

658

2250

2.09

63.40

1.1

294.53

420.30

mg/l

0.47

586

2029

Anxiety disorders

663

2267

2.09

63.34

1.1

294.71

419.32

mg/l

0.47

590

2045

Dystonia

131

7.38

62.96

1.1

1.0

287.61

290.14

mg/l

0.10

116

Depression medications

265

376

3.58

62.93

1.1

288.67

279.64

mg/l

0.75

238

347

Noninfective enteritis and colitis

374

1464

2.58

62.47

1.1

287.43

287.40

mg/l

0.00

340

1317

Implicit Sepsis

484

1623

2.33

62.07

1.1

295.95

286.43

mg/l

1.56

433

1448

Substance abuse

442

1786

2.38

62.05

1.1

288.06

283.38

mg/l

0.64

387

1621

Unspecified jaundice

9.35

61.89

1.1

1.0

318.28

288.31

mg/l

1.46

Diseases of the digestive system

321

1171

2.76

61.54

1.1

288.17

287.08

mg/l

0.08

287

1050

Inflammatory bowel disease

290

1007

2.91

61.41

1.1

287.87

284.97

mg/l

0.24

265

909

Mental and behavioural disorders due to psychoactive substance use

450

1818

2.35

61.25

1.1

287.65

283.48

mg/l

0.56

395

1650

Insulin medication

403

1390

2.50

61.22

1.1

296.93

285.69

mg/l

1.88

349

1259

Implicit bacterial Sepsis

257

760

3.13

60.58

1.1

1.0

303.80

286.02

mg/l

2.34

232

680

Symptoms and signs involving the nervous and musculoskeletal systems

405

1674

2.44

60.30

1.1

283.03

291.78

mg/l

1.59

387

1482

Gastro-oesophageal reflux disease

454

1734

2.33

60.00

1.1

284.31

461.82

mg/l

0.53

387

1574

Mental and behavioural disorders due to alcohol, excluding acute intoxication

349

1350

2.61

59.79

1.1

283.60

281.52

mg/l

0.19

305

1222

Chronic gastritis

197

550

3.62

59.77

1.1

285.83

292.41

mg/l

0.49

162

491

Other extrapyramidal and movement disorders in other diseases

188

512

3.73

59.29

1.1

1.0

281.64

291.11

mg/l

1.01

170

462

Biguanides

625

1842

2.10

59.10

1.1

284.39

454.04

mg/l

0.54

557

1657

Nutritional anaemias

322

1170

2.70

58.92

1.1

304.79

293.15

mg/l

1.72

279

1048

Oral corticosteroids

706

2153

1.99

57.77

1.1

291.66

427.06

mg/l

0.48

641

1923

Other nutritional deficiencies

462

2015

2.26

57.47

1.1

293.32

291.41

mg/l

0.21

397

1833

5-aminosalicylic acid

211

633

3.38

57.42

1.1

286.63

284.07

mg/l

0.18

189

570

Mood [affective] disorders

712

2390

1.97

57.41

1.1

708.18

289.74

mg/l

0.50

638

2152

Mental and behavioural disorders due to alcohol

382

1532

2.45

57.07

1.1

284.30

282.00

mg/l

0.23

336

1390

Renal failure

274

869

2.91

56.83

1.1

1.0

301.77

285.56

mg/l

2.51

254

770

Aplastic and other anaemias

284

961

2.83

56.42

1.1

1.0

296.01

289.23

mg/l

0.70

252

855

Other and unspecified anaemias

265

885

2.92

56.23

1.1

1.0

297.87

289.35

mg/l

0.97

234

784

Mood disorders

710

2395

1.96

56.22

1.1

709.51

289.85

mg/l

0.50

636

2157

Iron deficiency anaemia

282

1005

2.80

55.71

1.1

306.70

291.94

mg/l

2.26

245

901

IBD patients in KELA-register

231

746

3.14

55.71

1.1

285.18

284.93

mg/l

0.02

210

674

Depression

671

2346

1.98

55.48

1.1

732.19

289.68

mg/l

0.50

601

2113

Anxiety (asthma-related co-morbidities)

456

1593

2.27

55.27

1.1

293.95

290.14

mg/l

0.47

409

1442

Alcohol use disorder, ICD-based

322

1249

2.60

55.06

1.1

283.72

281.56

mg/l

0.20

282

1128

Other anaemias

265

895

2.88

54.81

1.1

1.0

297.87

289.10

mg/l

1.01

234

794

Hypertensive diseases (excluding secondary)

423

1023

2.42

54.61

1.1

291.81

287.68

mg/l

0.47

372

931

Insulin, intermediate and long-acting

372

1530

2.40

53.57

1.1

297.55

284.15

mg/l

2.40

324

1377

Inflammatory bowel disease, strict (require KELA)

231

764

3.07

53.50

1.1

285.18

284.97

mg/l

0.01

210

690

Other antidepressants

683

1806

1.98

53.03

1.1

287.43

452.54

mg/l

0.51

619

1638

Bacterial Sepsis

282

916

2.76

52.92

1.1

302.77

285.16

mg/l

2.57

254

818

Cholelithiasis, broad definition with cholecystitis

544

1787

2.10

52.56

1.1

293.40

459.63

mg/l

0.50

489

1600

Heart failure and antihypertensive medication

182

319

3.81

52.27

1.0

1.1

307.24

282.62

mg/l

3.39

165

287

Cholelithiasis

525

1751

2.11

52.05

1.1

292.26

463.41

mg/l

0.50

472

1565

Cholangitis (primary sclerosing, PSC), with reimbursement 202

13.07

51.87

1.1

1.0

319.74

289.42

mg/l

1.18

Hypothyroidism (congenital or acquired)

205

330

3.60

51.87

1.0

293.33

283.69

mg/l

0.71

175

310

Other gastritis (incl. Duodenitis)

177

508

3.53

51.63

1.1

1.0

283.14

287.98

mg/l

0.35

154

456

Other diseases of the digestive system

218

712

3.09

51.49

1.1

1.0

294.47

285.88

mg/l

0.80

194

639

Obesity and other hyperalimentation

435

1968

2.20

51.24

1.1

294.58

291.41

mg/l

0.38

370

1796

Insulin, combination of fast acting with intermediate-acting or long-acting

403

1638

2.28

51.10

1.1

296.93

284.37

mg/l

2.31

349

1475

Neurological diseases, wide definition

257

412

3.15

51.01

1.1

1.0

286.09

289.88

mg/l

0.25

235

389

GI-bleeding

216

706

3.09

50.95

1.1

1.0

295.46

285.45

mg/l

0.95

191

634

General examination and investigation of persons without complaint and reported diagnosis

423

959

2.36

50.58

1.1

291.21

286.50

mg/l

0.54

383

870

Psychiatric diseases

715

1870

1.92

50.46

1.1

285.81

291.30

mg/l

0.96

637

1692

Budesonide

144

365

4.02

50.45

1.1

1.0

295.44

286.39

mg/l

0.60

128

328

Ulcerative colitis

226

764

3.00

50.37

1.1

286.60

285.45

mg/l

0.07

204

689

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

174

505

3.50

50.02

1.1

282.41

284.43

mg/l

0.12

156

460

Hypothyroidism and >3 levothyroxin purchases

201

328

3.55

50.02

1.0

295.30

284.07

mg/l

0.87

172

308

Hypothyroidism, levothyroxine purchases

201

328

3.55

50.02

1.0

295.30

284.07

mg/l

0.87

172

308

Obesity

430

1957

2.19

50.01

1.1

294.96

291.44

mg/l

0.43

365

1785

Other disorders of fluid, electrolyte and acid-base balance

201

612

3.20

49.86

1.1

1.0

295.43

288.36

mg/l

0.39

174

542

Continuous positive airway pressure

137

281

4.25

49.82

1.0

1.1

282.23

286.06

mg/l

0.23

114

267

Acute renal failure

158

431

3.72

49.78

1.1

1.0

306.14

281.71

mg/l

2.92

148

383

Any mental disorder

720

1900

1.91

49.50

1.1

285.77

291.49

mg/l

1.04

644

1718

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

12.20

49.28

1.0

272.25

287.82

mg/l

0.48

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

351

904

2.48

48.96

1.1

294.09

289.79

mg/l

0.38

318

823

Other diseases of intestines

712

2210

1.88

48.92

1.1

291.73

421.16

mg/l

0.49

628

2020

Neurological diseases

607

1524

2.01

48.84

1.1

284.01

291.99

mg/l

1.55

541

1371

Ulcerative colitis (strict definition, require KELA)

177

529

3.40

48.61

1.1

283.74

283.84

mg/l

0.01

159

481

Hernia of abdominal wall, postoperative

113

244

4.68

48.61

1.0

1.1

293.65

286.41

mg/l

0.42

100

219

Cardiovascular diseases (excluding rheumatic etc)

492

1329

2.15

48.55

1.1

292.80

286.75

mg/l

0.76

446

1215

Antihypertensive medication - note that there are other indications

450

1104

2.24

48.39

1.1

288.32

288.01

mg/l

0.02

410

1009

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

185

570

3.30

48.37

1.1

282.68

284.37

mg/l

0.10

166

519

All anxiety disorders

462

1755

2.13

48.27

1.1

294.33

287.52

mg/l

1.07

414

1588

Septicaemia

253

895

2.74

47.69

1.1

1.0

304.75

286.61

mg/l

2.19

226

800

Explicit Sepsis

263

946

2.69

47.68

1.1

303.86

287.55

mg/l

1.94

236

847

Other septicaemia

231

801

2.85

47.23

1.1

1.0

305.13

285.53

mg/l

2.28

209

717

ILD medications: azathioprine

149

409

3.70

46.60

1.1

283.13

284.56

mg/l

0.07

134

371

Other bacterial diseases

598

2146

1.94

46.58

1.1

303.00

424.30

mg/l

0.42

535

1929

Other special examinations and investigations of persons without complaint or reported diagnosis

428

959

2.27

46.30

1.1

283.58

286.50

mg/l

0.27

389

870

Hypertension, essential

536

1512

2.03

45.76

1.1

288.89

481.64

mg/l

0.50

470

1374

Azathioprine

149

416

3.64

45.46

1.1

283.13

284.01

mg/l

0.05

134

378

Abdominal and pelvic pain

628

1637

1.94

45.36

1.1

284.15

288.27

mg/l

0.64

572

1486

Malaise and fatigue

306

1048

2.45

44.62

1.1

295.95

289.73

mg/l

0.51

278

920

Opioids

658

1843

1.88

44.27

1.1

288.65

449.79

mg/l

0.50

595

1660

Ulcerative colitis (strict definition, all Crohn cases excluded)

150

429

3.56

44.17

1.1

285.99

283.72

mg/l

0.12

136

390

Ulcerative colitis, NAS

146

411

3.61

44.04

1.1

282.04

284.40

mg/l

0.12

132

374

Certain infectious and parasitic diseases

656

1759

1.88

43.13

1.1

293.93

454.63

mg/l

0.47

599

1582

Mucosal proctocolitis

137

380

3.67

42.29

1.1

292.95

284.08

mg/l

0.60

123

344

Fever of other and unknown origin

343

1422

2.25

42.21

1.1

298.24

287.32

mg/l

1.34

316

1261

Hypertension

542

1570

1.96

42.00

1.1

292.01

475.02

mg/l

0.49

478

1426

Obesity due to excess calories

328

1453

2.28

41.97

1.1

292.96

290.43

mg/l

0.25

281

1319

Hypertensive diseases

542

1571

1.96

41.95

1.1

292.01

474.80

mg/l

0.49

478

1427

Persons encountering health services for examination and investigation

418

959

2.20

41.84

1.1

283.81

286.50

mg/l

0.26

377

870

Other and unspecified iron deficiency

213

778

2.76

41.16

1.0

311.58

293.24

mg/l

2.62

183

698

Reimbursement for rheumatic diseases

378

1791

2.12

40.60

1.1

297.34

457.32

mg/l

0.47

341

1599

Nausea and vomiting

172

556

3.07

40.14

1.1

296.84

288.40

mg/l

0.60

153

500

Abnormalities of breathing

586

1881

1.86

39.23

1.1

291.91

445.05

mg/l

0.49

523

1705

Second line medication for Crohn's disease

381

1844

2.08

38.96

1.1

288.83

289.95

mg/l

0.10

351

1653

Cardiovascular diseases

450

1202

2.05

38.91

1.1

292.18

286.26

mg/l

0.64

406

1100

Selective serotonin reuptake inhibitors

627

1819

1.82

38.28

1.1

283.72

450.97

mg/l

0.52

552

1650

Persons encountering health services for other counselling and medical advice, not elsewhere classified

685

2260

1.73

36.27

1.1

289.39

421.92

mg/l

0.50

628

2019

Cholecystectomy

416

1883

1.96

35.62

1.0

1.1

294.46

454.71

mg/l

0.50

373

1675

Other soft tissue disorders, not elsewhere classified

568

1942

1.81

35.60

1.1

295.25

289.86

mg/l

0.74

499

1764

Bleeding

482

1865

1.89

35.47

1.1

297.55

286.86

mg/l

2.19

424

1674

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

118

5.72

35.41

1.1

1.0

280.46

285.04

mg/l

0.14

103

Persons encountering health services in other circumstances, wide

738

2266

1.70

35.31

1.1

285.00

421.75

mg/l

0.53

675

2024

Depression or dysthymia

430

1208

2.00

35.19

1.1

283.85

290.68

mg/l

0.88

380

1103

Headache

404

1714

1.98

35.09

1.1

289.06

463.26

mg/l

0.50

372

1534

Pain in joint

369

1180

2.08

34.93

1.1

291.69

287.45

mg/l

0.46

330

1071

Other heart diseases

334

1033

2.15

34.27

1.0

1.1

298.60

286.85

mg/l

1.64

301

948

Chronic kidney disease

162

565

2.88

33.93

1.1

1.0

298.69

284.36

mg/l

1.19

147

499

Symptoms and signs involving the circulatory and respiratory systems

654

1893

1.74

33.87

1.1

288.35

443.96

mg/l

0.50

579

1715

Infections, IBD-co-morbidities

114

222

3.77

33.72

1.1

1.0

289.17

292.26

mg/l

0.16

101

207

Oedema, not elsewhere classified

186

701

2.66

33.54

1.1

1.0

292.98

291.48

mg/l

0.10

165

616

Benzodiazepine use

599

2471

1.73

33.11

1.1

292.98

409.96

mg/l

0.49

524

2232

Heart failure,strict

270

857

2.29

32.88

1.0

1.1

308.72

282.37

mg/l

6.08

249

762

Sleep disorders (combined)

601

2284

1.73

32.67

1.1

289.91

419.28

mg/l

0.50

534

2054

Hypokalaemia

228

4.05

32.52

1.1

1.0

282.54

293.47

mg/l

0.53

204

Pain (limb, back, neck, head abdominally)

467

1232

1.91

32.47

1.1

283.54

286.74

mg/l

0.36

427

1116

Codeine

574

1796

1.76

31.95

1.1

290.62

454.96

mg/l

0.50

522

1617

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

173

653

2.68

31.57

1.0

288.49

286.56

mg/l

0.12

153

587

Irritable bowel syndrome

188

748

2.53

30.79

1.1

285.14

293.42

mg/l

0.73

160

674

Dentinal caries

171

649

2.65

30.53

1.1

1.0

289.54

282.98

mg/l

0.36

151

595

Other anxiety disorders

310

1345

2.06

30.30

1.1

293.36

288.07

mg/l

0.56

278

1217

Dental caries

186

737

2.52

30.07

1.1

1.0

289.43

284.78

mg/l

0.26

166

671

Functional dyspepsia

170

652

2.63

30.04

1.0

1.1

291.96

292.36

mg/l

0.02

147

587

L04AX Other immunosuppressants

348

1793

1.95

30.01

1.1

290.00

289.69

mg/l

0.02

320

1607

Diarrhoea and gastroenteritis of presumed infectious origin

422

2098

1.84

29.74

1.1

297.97

286.93

mg/l

2.06

390

1884

Hypothyroidism, strict autoimmune

402

1411

1.89

29.41

1.1

295.48

498.59

mg/l

0.48

348

1272

Disorders of lipoprotein metabolism and other lipidaemias

452

1564

1.82

29.10

1.1

1.0

293.10

478.19

mg/l

0.48

402

1401

Lower back pain or/and sciatica

598

2499

1.67

28.65

1.1

287.21

410.85

mg/l

0.53

537

2242

Recurrent or chronic depression

271

915

2.15

28.64

1.1

290.34

290.83

mg/l

0.03

233

844

Intestinal infectious diseases

550

2537

1.69

28.63

1.1

295.96

406.03

mg/l

0.46

504

2272

Bacterial infection, other or unspecified

276

1198

2.09

28.31

1.1

309.81

285.00

mg/l

3.87

247

1070

Low back pain

440

1892

1.80

28.22

1.1

289.72

448.44

mg/l

0.51

397

1706

Sleep apnoea

543

2171

1.70

28.13

1.0

1.1

288.38

426.60

mg/l

0.51

484

1951

Insulin, fast-acting

226

1017

2.24

28.02

1.1

307.79

281.53

mg/l

4.56

197

916

Alcohol dependence

185

767

2.43

27.81

1.1

291.95

279.41

mg/l

1.36

166

698

Polyneuropathies and other disorders of the peripheral nervous system

141

516

2.76

27.41

1.1

1.0

298.18

285.14

mg/l

1.01

132

461

Asthma, excluding more controls

455

1350

1.80

27.21

1.1

294.72

506.62

mg/l

0.48

405

1211

Follow-up examination after treatment for conditions other than malignant neoplasms

248

741

2.20

27.19

1.0

299.26

291.46

mg/l

0.94

220

665

Renal tubulo-interstitial diseases

474

2110

1.73

26.59

1.1

297.77

432.73

mg/l

0.47

432

1878

Pain in throat and chest

502

1791

1.72

26.40

1.1

285.81

452.88

mg/l

0.51

448

1623

Heart failure, strict

280

985

2.06

26.37

1.0

308.58

284.31

mg/l

5.63

257

867

Other and unspecified polyneuropathies, also in other diseases

124

433

2.89

26.34

1.1

1.0

292.33

287.02

mg/l

0.29

116

385

Disorders of thyroid, IBD co-morbidities

112

257

3.20

26.12

1.0

306.37

298.13

mg/l

0.44

102

239

Dorsalgia

598

1975

1.65

26.02

1.1

286.39

440.17

mg/l

0.52

540

1786

Symptoms and signs involving cognition, perception, emotional state and behaviour

549

2337

1.65

25.63

1.1

288.28

418.50

mg/l

0.52

487

2103

Coagulation defects, purpura and other haemorrhagic conditions

137

512

2.70

25.62

1.1

1.0

294.81

287.53

mg/l

0.41

126

455

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

544

2139

1.66

25.59

1.1

292.24

429.63

mg/l

0.49

486

1920

Asthma, unspecified (mode), excluding more controls

296

1183

1.97

25.40

1.1

297.79

539.22

mg/l

0.47

263

1060

Soft tissue disorders

617

1987

1.62

24.94

1.1

289.76

289.08

mg/l

0.07

546

1802

Malignant neoplasm of liver and intrahepatic bile ducts

7.65

24.71

1.0

287.71

284.48

mg/l

0.06

Dyspnoea

487

2228

1.68

24.66

1.1

294.61

424.10

mg/l

0.48

438

1998

All-cause Heart Failure

269

958

2.03

24.64

1.0

308.45

284.32

mg/l

5.39

247

842

Parkinson's disease, strict definition, excluding more controls

165

4.08

24.63

1.0

1.1

280.38

295.43

mg/l

0.99

146

Insulin, fast-acting or short human

226

1073

2.12

24.56

1.1

307.79

281.27

mg/l

4.66

197

963

Other reaction to severe stress, and adjustment disorders

243

1191

2.05

24.31

1.1

296.20

289.22

mg/l

0.54

216

1077

Pure hypercholesterolaemia

376

1398

1.81

24.14

1.1

1.0

294.78

501.05

mg/l

0.48

329

1247

Systemic connective tissue disorders

200

913

2.21

24.07

1.1

299.77

294.77

mg/l

0.43

184

813

Personality disorders, excluding more controls

171

731

2.36

24.07

1.1

293.09

289.35

mg/l

0.27

147

662

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

178

775

2.31

24.00

1.1

296.79

290.59

mg/l

0.44

157

702

Sleep apnoea, including avohilmo

555

2225

1.62

23.92

1.0

1.1

290.07

422.87

mg/l

0.50

498

1999

Asthma

458

1429

1.73

23.74

1.1

294.87

495.73

mg/l

0.48

407

1280

Non-invasive ventilation

116

386

2.84

23.67

1.0

1.1

307.98

287.50

mg/l

1.45

104

365

Parkinson's disease, excluding more controls

191

3.76

23.59

1.0

1.1

276.08

297.42

mg/l

1.70

169

Constipation

475

2038

1.68

23.53

1.1

287.58

435.49

mg/l

0.52

405

1850

6-mercaptopurine

5.67

23.32

1.1

276.15

282.93

mg/l

0.19

Diseases of the skin and subcutaneous tissue

613

1933

1.60

23.25

1.1

293.82

439.87

mg/l

0.47

553

1737

Factors influencing health status and contact with health services

194

414

2.36

23.23

1.1

285.81

282.28

mg/l

0.20

175

374

Gastroduodenal ulcer

128

486

2.64

23.06

1.1

292.50

288.60

mg/l

0.22

113

436

Cardiac arrhythmias

355

1297

1.82

22.95

1.1

1139.87

292.05

mg/l

0.50

314

1179

Asthma, unspecified (mode)

297

1244

1.90

22.94

1.1

298.15

528.25

mg/l

0.47

264

1114

Asthma (only as main-diagnosis), excluding more controls

398

1350

1.76

22.79

1.0

1.1

296.93

506.62

mg/l

0.47

352

1211

Iron deficiency anaemia secondary to blood loss (chronic)

105

364

2.91

22.68

1.1

1.0

297.24

289.50

mg/l

0.45

327

Codeine or tramadol medication

652

2331

1.55

22.64

1.1

290.58

418.11

mg/l

0.50

587

2089

Crohn disease

108

386

2.83

22.09

1.1

287.48

285.39

mg/l

0.10

100

349

Hepatocellular carcinoma

8.80

22.02

1.0

284.61

290.04

mg/l

0.09

Other symptoms and signs involving the digestive system and abdomen

102

354

2.91

21.98

1.0

298.09

296.45

mg/l

0.08

318

Other symptoms and signs involving cognitive functions and awareness

219

1002

2.06

21.98

1.0

287.34

290.14

mg/l

0.21

193

898

Implicit viral Sepsis

112

409

2.76

21.95

1.1

1.0

293.94

286.60

mg/l

0.38

369

Viral Sepsis

112

411

2.75

21.76

1.1

1.0

293.94

286.62

mg/l

0.38

370

Asthma (mode)

443

1448

1.69

21.34

1.1

295.43

493.12

mg/l

0.47

395

1295

Atrial fibrillation and flutter

186

546

2.24

21.24

1.0

1867.56

282.01

mg/l

0.51

170

492

Purpura and other haemorrhagic conditions

101

356

2.87

21.22

1.1

1.0

299.16

290.46

mg/l

0.42

317

Diseases of pulp and periapical tissues

212

1044

2.04

21.02

1.1

1.0

287.08

287.18

mg/l

0.01

183

946

Episodal and paroxysmal disorders

640

2137

1.54

21.01

1.1

285.68

292.12

mg/l

1.33

571

1920

Thrombocytopenia, unspecified

167

3.84

21.00

1.1

1.0

290.98

286.35

mg/l

0.13

150

Benign neoplasm of colon, rectum, anus and anal canal

301

1497

1.82

20.92

1.0

1.1

293.69

289.65

mg/l

0.37

259

1337

Bipolar affective disorders

140

585

2.41

20.85

1.1

1.0

290.75

287.15

mg/l

0.22

128

538

Myalgia

148

634

2.35

20.83

1.1

289.42

291.42

mg/l

0.12

130

574

Special screening examination for infectious and parasitic diseases

167

549

2.29

20.79

1.1

281.64

283.57

mg/l

0.11

143

502

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

5.51

20.77

1.1

1.0

290.47

294.98

mg/l

0.10

Other systemic involvement of connective tissue (FG)

151

649

2.33

20.72

1.1

299.29

295.34

mg/l

0.26

140

585

Benign neoplasm: Colon

253

1304

1.91

20.63

1.0

1.1

290.51

289.55

mg/l

0.08

219

1161

Other heart diseases, wide

546

2161

1.57

20.51

1.0

1.1

295.08

287.10

mg/l

1.47

483

1954

Obesity, other/unspecified

209

1034

2.03

20.49

1.1

300.14

291.67

mg/l

0.84

181

942

Haemorrhage from respiratory passages

175

749

2.18

20.32

1.0

308.84

284.86

mg/l

3.65

152

670

Asthma (only as main-diagnosis)

401

1429

1.70

20.32

1.0

1.1

297.25

495.73

mg/l

0.47

355

1280

Fibromyalgia

209

3.44

20.25

1.1

1.0

305.19

293.49

mg/l

0.55

189

Hypothyroidism, drug reimbursement

200

3.17

20.19

1.1

1.0

302.53

291.29

mg/l

0.61

188

Exposure to unspecified factor

536

2683

1.55

19.99

1.1

844.81

289.61

mg/l

0.50

483

2411

Use of hypnotics and sedatives

591

2227

1.54

19.95

1.1

293.52

422.64

mg/l

0.48

526

1999

Diseases of arteries, arterioles and capillaries (FINNGEN)

137

390

2.47

19.87

1.1

1.0

296.95

279.98

mg/l

1.41

113

355

Acute pancreatitis

114

444

2.59

19.73

1.1

1.0

280.96

284.21

mg/l

0.18

104

400

Pain in limb

416

1832

1.65

19.51

1.1

302.38

290.49

mg/l

1.89

367

1665

Excluding asthma or asthma-COPD overlap

469

1446

1.63

19.51

1.1

288.13

493.08

mg/l

0.50

420

1297

Finngen Rheumatological endpoints

566

2094

1.55

19.43

1.0

1.1

288.09

431.14

mg/l

0.51

502

1891

Hypothyroidism, other/unspecified

480

1998

1.59

19.23

1.1

297.08

441.18

mg/l

0.48

420

1795

Diseases of the musculoskeletal system and connective tissue

358

1034

1.74

19.08

1.1

285.56

289.07

mg/l

0.30

328

946

Neoplasms

476

1592

1.61

19.07

1.1

284.31

468.56

mg/l

0.50

437

1457

Dialysis, with operation codes

317

2.87

18.98

1.1

1.0

288.73

280.48

mg/l

0.36

282

Fall on same level

656

2465

1.49

18.98

1.1

289.17

290.03

mg/l

0.09

584

2229

Other systemic involvement of connective tissue

155

705

2.21

18.97

1.1

1.0

299.05

295.58

mg/l

0.23

144

626

Other pulmonary diagnosis

466

1446

1.62

18.92

1.1

287.56

493.08

mg/l

0.50

418

1297

Disorders of the thyroid gland

512

2150

1.56

18.90

1.1

298.21

429.40

mg/l

0.47

449

1937

Benign neoplasms

467

1651

1.61

18.84

1.1

289.38

462.37

mg/l

0.49

422

1509

Atrial fibrillation and flutter with reimbursement

145

395

2.37

18.82

1.0

1.1

2321.92

278.11

mg/l

0.51

132

356

Gastric ulcer

324

2.83

18.77

1.1

1.0

294.75

289.24

mg/l

0.27

290

Other specific joint derangements/joint disorders

429

1781

1.62

18.61

1.1

289.81

456.05

mg/l

0.50

380

1606

Hypothyreosis and Thyroxine purchase for inclusion criteria

491

2073

1.57

18.52

1.1

296.62

436.17

mg/l

0.48

430

1864

Hyperkalaemia

4.84

18.50

1.1

1.0

316.83

288.77

mg/l

1.44

Convulsions, not elsewhere classified

143

628

2.26

18.44

1.1

282.60

283.14

mg/l

0.03

127

564

Other noninfective gastroenteritis and colitis

148

668

2.23

18.43

1.0

1.1

290.81

287.85

mg/l

0.17

135

597

Chronic laryngitis and laryngotracheitis

356

2.72

18.38

1.0

1.1

284.15

288.26

mg/l

0.19

323

Intracranial trauma

309

1321

1.75

18.38

1.1

1211.22

292.78

mg/l

0.49

285

1190

Persons encountering health services in other circumstances

215

1116

1.93

18.37

1.1

283.91

287.60

mg/l

0.30

203

999

Phobic anxiety disorders

103

397

2.62

18.26

1.1

288.80

286.07

mg/l

0.13

361

COPD differential diagnosis

463

1448

1.61

18.23

1.1

289.07

493.12

mg/l

0.49

416

1295

ILD differential diagnosis

463

1448

1.61

18.23

1.1

289.07

493.12

mg/l

0.49

416

1295

Unspecified kidney failure

175

3.53

18.12

1.1

1.0

295.47

285.83

mg/l

0.35

153

Hypo-osmolality and hyponatraemia

314

2.82

17.99

1.1

307.04

288.05

mg/l

0.60

279

Erysipelas

268

1367

1.80

17.89

1.1

298.32

282.92

mg/l

2.05

236

1223

Benign neoplasm: Colon

250

1039

1.85

17.87

1.0

1.1

290.47

570.35

mg/l

0.49

217

933

Other symptoms and signs involving the nervous and musculoskeletal systems

231

1240

1.87

17.87

1.1

279.23

293.76

mg/l

2.74

217

1095

Complications of surgical and medical care, not elsewhere classified

515

2421

1.53

17.72

1.1

297.58

412.79

mg/l

0.46

457

2178

Non-ischemic cardiomyopathy

143

523

2.26

17.71

1.0

306.36

288.04

mg/l

2.12

131

458

Other dorsopathies, not elsewhere classified

571

1995

1.51

17.63

1.1

288.76

438.42

mg/l

0.51

517

1802

Dorsopathies

592

2015

1.50

17.56

1.1

290.90

436.58

mg/l

0.50

534

1820

Complications of medical and surgical care

374

2190

1.63

17.52

1.1

293.17

427.44

mg/l

0.50

326

1971

Other external causes of accidental injury

482

1538

1.57

17.50

1.0

1.1

292.72

289.55

mg/l

0.34

428

1388

Accidents

482

1538

1.57

17.50

1.1

293.06

289.55

mg/l

0.39

432

1388

Cerebrovascular diseases (FINNGEN)

175

603

2.09

17.35

1.1

1.0

294.69

284.43

mg/l

1.00

160

546

Sciatica+with lumbago

276

1501

1.75

17.10

1.0

1.1

279.85

490.02

mg/l

0.54

246

1347

Benign neoplasm of colon, rectum, anus and anal canal

285

1163

1.76

16.97

1.0

293.32

539.59

mg/l

0.48

247

1048

Oxycodone

170

808

2.04

16.96

1.1

311.95

288.89

mg/l

2.89

147

720

Other ulcerative colitis

162

3.52

16.51

1.1

1.0

290.96

287.12

mg/l

0.13

144

Benign neoplasms

548

2048

1.50

16.33

1.1

288.23

431.50

mg/l

0.50

493

1864

Chronic pancreatitis

282

2.83

16.32

1.1

279.08

282.67

mg/l

0.14

251

Other diseases of intestine

266

2.89

16.27

1.1

1.0

298.54

288.17

mg/l

0.54

237

Combinations of oral blood glucose lowering drugs

139

645

2.17

16.26

1.0

286.51

284.34

mg/l

0.13

124

577

Dysphagia

114

489

2.34

16.10

1.1

1.0

292.68

290.23

mg/l

0.11

103

434

Benign neoplasm of other and ill-defined parts of digestive system

105

435

2.43

16.07

1.1

1.0

290.07

292.44

mg/l

0.10

391

Other diseases of pancreas

160

3.49

16.06

1.1

1.0

287.43

285.46

mg/l

0.06

142

Polyarthropathies

373

1545

1.61

16.02

1.0

1.1

294.67

481.61

mg/l

0.48

343

1391

Concussion

258

1274

1.76

16.00

1.1

1398.11

292.03

mg/l

0.49

238

1150

Dermatitis and eczema

584

2624

1.46

15.99

1.1

301.81

400.86

mg/l

0.42

533

2349

Nephropathy related operations

316

2.69

15.72

1.1

1.0

282.61

281.17

mg/l

0.05

281

Other functional intestinal disorders

214

1112

1.84

15.66

1.1

295.08

290.25

mg/l

0.36

184

1005

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

120

3.52

15.62

1.0

290.69

294.95

mg/l

0.16

110

Acute upper respiratory infections

555

2367

1.47

15.60

1.1

296.60

415.96

mg/l

0.47

502

2121

Persons encountering health services for specific procedures and health care

586

2500

1.46

15.49

1.1

296.14

406.62

mg/l

0.46

515

2258

Other disorders of skin and subcutaneous tissue

334

1893

1.62

15.46

1.1

302.97

447.83

mg/l

0.45

291

1694

Benign neoplasm of other and ill-defined parts of digestive system

105

443

2.39

15.45

1.1

1.0

290.07

290.10

mg/l

0.00

397

612

2233

1.45

15.42

1.1

297.34

422.56

mg/l

0.46

555

2004

Complications of procedures, not elsewhere classified

410

2300

1.54

15.30

1.1

295.74

420.04

mg/l

0.48

368

2068

Disorder of lipoprotein metabolism, unspecified

255

2.85

15.11

1.0

294.03

287.55

mg/l

0.29

226

Other disorders of urethra and urinary system

347

1624

1.61

14.96

1.0

1.1

294.84

481.77

mg/l

0.51

310

1452

Other disorders of skin and subcutaneous tissue, not elsewhere classified

360

2.52

14.88

1.1

1.0

303.63

285.97

mg/l

1.09

323

Other diseases of upper respiratory tract

589

2122

1.45

14.83

1.1

287.03

430.07

mg/l

0.52

517

1921

Falls/tendency to fall

622

2171

1.44

14.82

1.1

295.81

289.24

mg/l

1.02

551

1966

Abnormalities of heart beat

176

913

1.92

14.80

1.1

284.90

290.72

mg/l

0.51

153

820

Polycystic ovarian syndrome, consortium definition

361

1370

1.59

14.52

1.1

303.17

522.77

mg/l

0.50

323

1218

Abnormal findings on diagnostic imaging of lung

208

1125

1.81

14.47

1.1

1.0

301.34

286.72

mg/l

2.06

190

1007

Use of levodopa decarboxylase inhibitor

257

2.79

14.33

1.0

270.87

285.20

mg/l

1.02

226

Vocal cord dysfunction

233

2.81

14.15

1.0

1.1

279.62

288.05

mg/l

0.52

214

Social phobias

232

2.88

14.09

1.1

294.03

285.83

mg/l

0.36

209

Dipeptidyl peptidase 4 (DPP-4) inhibitors

212

2.95

13.90

1.1

1.0

292.64

284.59

mg/l

0.34

188

External causes of morbidity and mortality

385

1234

1.57

13.87

1.1

292.52

289.41

mg/l

0.28

348

1120

Statin medication

416

1529

1.53

13.82

1.1

291.43

483.19

mg/l

0.49

374

1371

172

3.18

13.70

1.1

1.0

289.73

285.05

mg/l

0.09

155

Sulfonylureas

132

505

2.09

13.67

1.0

297.30

289.78

mg/l

0.57

117

450

L04AD Calcineurin inhibitors

322

2.54

13.64

1.1

295.05

286.22

mg/l

0.28

292

Parkinson's disease, including avohilmo

305

2.58

13.55

1.0

273.28

285.43

mg/l

0.86

266

Acute pancreatitis (for exclusion)

114

528

2.17

13.51

1.1

1.0

280.96

284.12

mg/l

0.18

104

476

Diverticular disease of intestine

333

1398

1.59

13.43

1.0

295.23

499.24

mg/l

0.48

281

1271

Acute upper respiratory infections of multiple and unspecified sites

403

2002

1.51

13.42

1.1

298.53

288.82

mg/l

1.23

359

1801

Type 1 diabetes

142

715

1.99

13.40

1.1

310.29

281.80

mg/l

3.27

125

645

Hypothyroidism, strict autoimmune, 3 medication purchases required

423

1927

1.50

13.37

1.1

298.22

447.87

mg/l

0.48

368

1733

Elevated blood glucose level

185

3.06

13.37

1.1

1.0

279.22

287.72

mg/l

0.29

165

Pain, not elsewhere classified

139

697

2.00

13.33

1.1

298.00

289.03

mg/l

0.59

130

614

Other joint disorders

503

1839

1.46

13.24

1.1

286.95

450.44

mg/l

0.51

450

1658

Gout, FINNGEN

124

599

2.08

13.17

1.0

293.44

282.03

mg/l

0.86

109

537

Heart failure and bmi 25plus

167

603

1.92

13.16

1.0

1.1

306.25

279.10

mg/l

4.38

156

525

Personality disorders

171

925

1.86

13.11

1.1

293.09

287.38

mg/l

0.47

147

840

Gout

124

544

2.09

13.08

1.0

293.44

285.22

mg/l

0.54

109

488

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

495

2329

1.45

13.06

1.1

294.20

417.69

mg/l

0.48

453

2082

Bronchitis

553

2560

1.42

13.05

1.1

297.03

404.57

mg/l

0.46

487

2309

Nerve, nerve root and plexus disorders

537

2369

1.43

12.95

1.1

842.85

290.92

mg/l

0.50

483

2122

COPD/asthma/ILD related infections

564

1987

1.42

12.87

1.1

295.22

438.35

mg/l

0.47

512

1779

COPD/asthma related infections

564

1987

1.42

12.87

1.1

295.22

438.35

mg/l

0.47

512

1779

Other blood glucose lowering drugs, excl. Insulins

331

2.46

12.85

1.1

281.91

287.10

mg/l

0.29

292

Symptoms and signs involving the urinary system

367

1864

1.53

12.84

1.1

284.67

289.43

mg/l

0.58

318

1674

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

178

982

1.82

12.81

1.1

296.79

287.26

mg/l

0.81

157

892

Disorders of adult personality and behaviour

179

990

1.82

12.79

1.1

297.73

287.39

mg/l

0.87

153

903

Poisoning by drugs, medicaments and biological substances

154

813

1.91

12.75

1.1

293.02

286.35

mg/l

0.41

129

737

Infections of the skin and subcutaneous tissue

307

1953

1.57

12.68

1.1

300.53

284.11

mg/l

2.26

281

1761

Other diseases of hard tissues of teeth

333

1600

1.56

12.66

1.1

1.0

283.06

472.87

mg/l

0.52

295

1448

Symptoms and signs involving the skin and subcutaneous tissue

339

2210

1.53

12.51

1.1

293.08

427.42

mg/l

0.49

315

1967

Other and unspecified disorders of skin and subcutaneous tissue

156

3.18

12.48

1.1

1.0

309.12

289.19

mg/l

0.63

139

Asthma, hospital admission 2, infections

286

1775

1.59

12.46

1.1

301.77

288.42

mg/l

1.81

253

1602

Asthma-related infections

286

1775

1.59

12.46

1.1

301.77

288.42

mg/l

1.81

253

1602

Gout, strict definition

361

2.37

12.42

1.0

290.71

281.13

mg/l

0.52

323

Parkinson's disease

290

2.54

12.32

1.0

276.08

285.37

mg/l

0.57

254

459

1982

1.45

12.28

1.1

300.33

438.57

mg/l

0.45

420

1776

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

459

1982

1.45

12.28

1.1

300.33

438.57

mg/l

0.45

420

1776

Noninfectious colitis NAS

358

2.37

12.19

1.0

295.83

292.35

mg/l

0.14

321

Injuries to the head

564

2637

1.40

12.12

1.1

794.63

292.40

mg/l

0.48

518

2357

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

288

1827

1.58

12.10

1.0

1.1

295.91

292.80

mg/l

0.24

253

1644

Rheumatism, unspecified

372

2.33

12.07

1.1

306.68

293.78

mg/l

1.02

334

Irregular menses

249

1234

1.64

12.04

1.1

299.93

545.08

mg/l

0.51

230

1102

Poisoning by medicine

140

731

1.93

12.02

1.1

296.68

286.85

mg/l

0.64

117

669

Diaphragmatic hernia

169

937

1.81

11.99

1.1

301.71

289.82

mg/l

1.25

148

841

Erosion of teeth, including avohilmo

116

547

2.06

11.97

1.1

1.0

288.29

289.74

mg/l

0.05

102

500

Cough

201

1125

1.72

11.89

1.1

1.0

292.53

290.45

mg/l

0.13

180

1015

Other CVD (FINNGEN)

155

2.92

11.89

1.1

290.67

277.37

mg/l

0.51

142

Genitourinary diseases

362

1189

1.53

11.85

1.1

280.84

530.01

mg/l

0.51

333

1079

Chronic periapical parodontitis

113

550

2.07

11.83

1.1

1.0

283.08

286.26

mg/l

0.18

100

502

Other bacterial intestinal infections

426

2.22

11.82

1.1

1.0

292.98

285.76

mg/l

0.45

377

Injuries to the knee and lower leg

614

2564

1.37

11.71

1.1

290.18

405.86

mg/l

0.50

545

2310

Gout, unspecified

409

2.24

11.68

1.0

295.73

282.61

mg/l

0.79

367

Somatoform disorder

461

2.16

11.65

1.1

1.0

285.15

290.12

mg/l

0.26

420

Dizziness and giddiness

351

1902

1.50

11.55

1.1

287.41

448.63

mg/l

0.52

313

1707

Hypertensive Heart Disease

341

2.24

11.53

1.0

295.54

284.61

mg/l

0.68

308

Benign neoplasm: Colon, unspecified

111

540

2.06

11.49

1.1

1.0

290.94

287.93

mg/l

0.17

482

Chronic lower respiratory diseases

637

2533

1.36

11.47

1.1

296.09

405.09

mg/l

0.46

570

2278

Early onset COPD, excluding more controls

105

503

2.10

11.46

1.0

1.1

304.30

282.72

mg/l

2.05

445

Gout, idiopatic and unspecified

106

510

2.09

11.46

1.0

292.85

281.39

mg/l

0.76

457

Symptoms and signs involving speech and voice

160

886

1.81

11.44

1.1

288.85

293.90

mg/l

0.38

143

793

Coeliac disease

332

2.37

11.39

1.2

1.0

283.45

290.93

mg/l

0.35

303

Parkinson's disease, strict definition

272

2.52

11.35

1.0

280.38

286.81

mg/l

0.36

237

Papulosquamous disorders

201

1191

1.70

11.34

1.0

1.1

295.55

288.42

mg/l

0.54

181

1061

Cholecystitis

267

2.53

11.27

1.1

1.0

298.09

291.45

mg/l

0.15

236

Obesity related asthma

177

1018

1.75

11.14

1.1

290.94

289.85

mg/l

0.08

154

914

Speech disturbances, not elsewhere classified

189

2.83

11.11

1.0

282.50

290.18

mg/l

0.29

166

Migraine

258

1385

1.59

11.06

1.1

287.64

296.82

mg/l

1.21

239

1248

Excessive, frequent and irregular menstruation

204

661

1.72

10.99

1.1

297.53

753.11

mg/l

0.51

176

593

Chronic periodontitis

377

2.24

10.86

1.1

1.0

295.66

286.25

mg/l

0.55

340

Shoulder lesions

376

1568

1.47

10.72

1.0

1.1

288.98

290.30

mg/l

0.12

336

1414

Hyperkinetic disorders, excluding more controls

243

2.54

10.69

1.1

276.07

284.93

mg/l

0.39

226

Maternal care for other conditions predominantly related to pregnancy

120

612

1.95

10.65

1.1

302.92

303.62

mg/l

0.03

106

551

Chronic sinusitis

218

1343

1.63

10.59

1.1

294.32

292.13

mg/l

0.16

194

1215

Other and unspecified dermatitis

244

1551

1.58

10.43

1.1

299.23

288.94

mg/l

1.07

224

1381

Abnormal findings on diagnostic imaging of other body structures

302

2.37

10.42

1.1

1.0

297.02

289.85

mg/l

0.38

269

Other diseases of anus and rectum

129

688

1.88

10.40

1.1

299.45

292.41

mg/l

0.45

119

620

Influenza and pneumonia

541

2606

1.37

10.39

1.1

296.12

402.29

mg/l

0.46

492

2339

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

260

1642

1.56

10.39

1.0

1.1

280.65

289.19

mg/l

1.12

225

1496

Parasetamol

461

1665

1.42

10.36

1.0

1.1

291.18

286.34

mg/l

0.57

417

1506

Benign neoplasm: Colon, unspecified

111

565

1.98

10.33

1.1

1.0

290.94

286.19

mg/l

0.30

507

Asthma, including avohilmo

603

2605

1.35

10.31

1.1

296.63

402.05

mg/l

0.45

536

2346

227

1411

1.60

10.31

1.1

303.01

287.96

mg/l

1.76

200

1280

Panic disorder

425

2.13

10.28

1.2

1.1

294.33

290.26

mg/l

0.19

386

Gingivitis and periodontal diseases

450

1640

1.42

10.28

1.1

1.0

287.64

468.72

mg/l

0.50

388

1482

Menorrhagia

183

583

1.74

10.27

1.1

305.58

816.67

mg/l

0.50

161

519

Vascular disorders of the intestines

107

3.40

10.26

1.0

297.39

301.17

mg/l

0.10

Hypertensive heart and/or renal disease

100

374

2.08

10.26

1.0

295.64

285.21

mg/l

0.69

341

Symptoms and signs concerning food and fluid intake

220

2.61

10.26

1.1

1.0

277.02

289.65

mg/l

0.63

192

Diseases of oral cavity, salivary glands and jaws

454

1648

1.42

10.22

1.1

1.0

285.84

467.76

mg/l

0.51

403

1490

Cystitis

404

1722

1.44

10.22

1.1

294.60

470.14

mg/l

0.51

366

1544

Osteopathies and chondropathies

259

1588

1.55

10.21

1.1

298.60

290.18

mg/l

0.77

223

1418

Bacterial intestinal infections, IBD co-morbidities

446

2.10

10.20

1.1

1.0

294.01

288.36

mg/l

0.33

398

Psoriasis

153

868

1.77

10.15

1.1

298.88

285.84

mg/l

0.97

138

781

Spondyloarthritis

487

2.04

10.14

1.1

292.20

285.14

mg/l

0.40

439

Other diseases of blood and blood-forming organs, wide

117

611

1.93

10.12

1.0

317.77

288.06

mg/l

2.04

101

547

Abnormal weight loss

199

2.69

10.11

1.1

1.0

278.42

294.56

mg/l

0.79

177

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

110

564

1.96

10.06

1.1

297.77

288.43

mg/l

0.47

520

Dermatitis

285

1891

1.51

10.04

1.1

305.34

445.72

mg/l

0.43

261

1692

Unspecified urinary incontinence

183

2.76

10.02

1.1

1.0

286.83

298.03

mg/l

0.52

157

Chronic periodontitis, including avohilmo

438

2315

1.40

10.02

1.1

294.05

417.35

mg/l

0.48

382

2090

Certain disorders involving the immune mechanism

110

565

1.96

10.01

1.1

1.0

306.30

283.32

mg/l

2.12

102

509

Asthma, hospital admissions , main diagnosis only

411

2617

1.41

9.93

1.1

297.45

402.69

mg/l

0.46

365

2359

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

261

1705

1.53

9.88

1.0

1.1

292.56

291.81

mg/l

0.06

229

1528

Other/unspecified dorsalgia

181

1081

1.67

9.79

1.1

294.25

292.23

mg/l

0.10

165

966

Other intervertebral disc disorders

408

1760

1.42

9.77

1.1

287.62

459.99

mg/l

0.52

366

1587

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

180

2.75

9.77

1.1

317.48

290.75

mg/l

0.90

166

Pain and other conditions associated with female genital organs and menstrual cycle

110

545

1.95

9.77

1.1

317.89

304.96

mg/l

0.79

495

Direct fill therapy

401

2.14

9.76

1.0

1.1

312.42

287.24

mg/l

1.62

361

Parodontitis

438

2317

1.40

9.76

1.1

293.85

417.17

mg/l

0.48

382

2092

Glomerular diseases

488

2.02

9.74

1.1

1.0

307.71

284.13

mg/l

1.77

440

Parodontitis or operation codes

438

2318

1.39

9.69

1.1

293.85

417.07

mg/l

0.48

382

2093

Substance use, excluding alcohol

117

621

1.90

9.67

1.1

302.02

282.34

mg/l

2.27

103

567

Suicide or other Intentional self-harm

146

830

1.77

9.65

1.1

298.52

285.95

mg/l

0.99

126

750

Chronic diseases of tonsils and adenoids

427

1928

1.41

9.62

1.1

286.66

442.32

mg/l

0.52

380

1753

Spondylopathies

378

1600

1.44

9.61

1.1

287.24

477.12

mg/l

0.52

335

1441

Care involving dialysis

193

2.67

9.61

1.1

289.46

278.55

mg/l

0.40

175

Arthropathies

498

1843

1.38

9.59

1.1

281.57

450.05

mg/l

0.53

454

1662

Sicca syndrome [Sjögren]

205

2.61

9.56

1.0

304.04

296.70

mg/l

0.32

176

Diagnoses used for exclusion with ILD

122

659

1.86

9.54

1.0

303.32

285.07

mg/l

1.73

114

591

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

223

2.54

9.52

1.1

315.49

289.81

mg/l

0.93

200

Disorders of other endocrine glands

209

1289

1.60

9.50

1.1

300.40

289.76

mg/l

0.87

189

1157

Exposure to other specified factors

375

2484

1.42

9.50

1.1

283.74

288.96

mg/l

0.64

331

2247

Syncope and collapse

184

987

1.66

9.47

1.1

290.73

287.46

mg/l

0.18

167

868

Injuries to the ankle and foot

361

2315

1.42

9.30

1.1

289.28

288.56

mg/l

0.06

332

2083

Weight loss

220

2.52

9.27

1.1

1.0

275.93

296.10

mg/l

1.13

197

Disorders of lens

319

1370

1.47

9.25

1.0

1.1

286.10

506.37

mg/l

0.51

276

1230

Asthma (diagnoses ohter than nonallergic)

423

2618

1.38

9.20

1.1

297.60

402.44

mg/l

0.45

374

2364

Specific personality disorders

141

806

1.76

9.17

1.1

294.57

287.11

mg/l

0.57

119

737

Non-selective monoamine reuptake inhibitors

174

1021

1.66

9.14

1.1

1.0

296.71

580.79

mg/l

0.49

157

919

Other diseases of urinary system

498

2062

1.36

9.12

1.1

290.51

437.04

mg/l

0.51

447

1853

Use of pramipexole

102

529

1.94

9.06

1.0

295.77

289.12

mg/l

0.41

473

Diseases of the respiratory system

334

1145

1.46

9.03

1.0

1.1

293.75

548.31

mg/l

0.49

299

1026

L04AA Selective immunosuppressants

121

665

1.83

9.00

1.0

1.1

287.78

287.68

mg/l

0.00

113

592

Coxibs

143

424

1.80

8.96

1.1

300.48

294.70

mg/l

0.27

128

383

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

230

2.46

8.95

1.1

1.0

315.49

298.45

mg/l

0.53

206

Other CVD

363

2.13

8.88

1.1

1.0

289.27

286.95

mg/l

0.08

321

Diseases of arteries, arterioles and capillaries

275

1378

1.49

8.82

1.1

297.07

286.36

mg/l

1.30

233

1243

Diseases of peritoneum

256

2.36

8.82

1.1

1.0

287.38

289.07

mg/l

0.06

233

Glomerular disorders in diseases classified elsewhere

300

2.25

8.81

1.1

1.0

315.49

285.24

mg/l

2.09

268

Cardiomyopathy

392

2.08

8.74

1.0

1.1

304.62

279.44

mg/l

2.06

352

Intrahepatic Cholestasis of Pregnancy (ICP)

191

2.59

8.74

1.1

1.0

317.48

300.48

mg/l

0.48

176

Diseases of the eye and adnexa

478

1758

1.36

8.70

1.1

288.82

453.30

mg/l

0.49

430

1599

Infections with a predominantly sexual mode of transmission

173

1061

1.64

8.66

1.1

292.29

290.49

mg/l

0.08

148

959

Type 1 diabetes, wide definition, subgroup 1

110

594

1.86

8.63

1.2

1.1

317.71

281.27

mg/l

3.88

539

Parodontitis and operation codes

408

2303

1.38

8.62

1.1

293.52

418.31

mg/l

0.48

356

2076

Generalized anxiety disorder

457

1.98

8.53

1.1

293.83

289.74

mg/l

0.19

417

Cutaneous abscess, furuncle and carbuncle

135

780

1.74

8.50

1.1

1.0

316.91

283.33

mg/l

3.00

116

702

Unspecified mental disorder

220

1435

1.54

8.49

1.1

291.21

287.06

mg/l

0.37

198

1299

KRA_PSY_EATING, excluding more controls

159

2.71

8.44

1.1

292.61

309.36

mg/l

0.60

149

Hernia of abdominal wall

203

1304

1.56

8.41

1.1

287.72

284.49

mg/l

0.26

183

1169

Schizophrenia or delusion, excluding more controls

149

881

1.68

8.36

1.1

288.15

284.74

mg/l

0.23

137

803

Intracranial injury

265

1740

1.48

8.36

1.1

1384.73

288.40

mg/l

0.49

241

1567

Ulcer of lower limb, not elsewhere classified

295

2.22

8.29

1.0

301.88

278.39

mg/l

1.44

262

All pneumoniae

500

2596

1.33

8.26

1.1

298.47

402.88

mg/l

0.44

458

2325

Psoriasis vulgaris

104

561

1.86

8.25

1.1

1.0

297.23

285.46

mg/l

0.57

505

Pneumonias (Asthma/COPD co-morbidities)

496

2583

1.33

8.25

1.1

299.56

403.01

mg/l

0.43

454

2316

Acute alcohol intoxication

125

713

1.76

8.24

1.0

1.1

287.71

282.36

mg/l

0.36

116

648

Ulcerative enterocolitis

3.39

8.24

1.1

1.0

292.48

286.27

mg/l

0.13

Explicit bacterial Sepsis

221

2.41

8.21

1.1

1.0

292.70

287.57

mg/l

0.18

196

Open wound of head

240

1582

1.50

8.21

1.1

278.11

284.55

mg/l

0.75

222

1415

Familial hypercholesterolemia

284

2.23

8.16

1.0

291.87

283.85

mg/l

0.38

248

L04AC Interleukin inhibitors

146

2.78

8.15

1.1

282.63

291.02

mg/l

0.21

132

Other headache syndromes

203

1319

1.54

8.01

1.1

1742.06

296.39

mg/l

0.49

183

1182

Acute tubulo-interstitial nephritis

258

1558

1.47

7.99

1.1

297.08

292.64

mg/l

0.42

231

1384

Care involving use of rehabilitation procedures

301

2008

1.43

7.97

1.1

298.61

436.13

mg/l

0.46

264

1809

Other diseases of lip and oral mucosa

407

2.00

7.94

1.1

1.0

291.92

290.41

mg/l

0.06

367

Hyperlipidaemia, other/unspecified

147

837

1.67

7.93

1.1

292.73

288.20

mg/l

0.31

131

744

Cerebral cysts

154

2.69

7.91

1.1

268.28

292.46

mg/l

1.25

138

Biological medication for rheuma

520

1.88

7.88

1.1

276.76

284.94

mg/l

0.48

474

Presence of cardiac and vascular implants and grafts

173

817

1.61

7.79

1.0

298.91

285.64

mg/l

1.31

158

720

Cardiomyopathies, Primary/intrinsic

277

2.22

7.79

1.0

1.1

305.11

274.21

mg/l

2.13

256

Chronic periodontitis, complicated

252

2.28

7.78

1.0

293.22

282.86

mg/l

0.52

228

Behavioural syndromes associated with physiological disturbances and physical factors

167

1047

1.60

7.71

1.1

297.31

288.59

mg/l

0.60

149

950

Pleural effusion

311

2.13

7.69

1.0

335.69

281.20

mg/l

2.91

273

Diseases of pulp and periapical tissues, including avohilmo

537

2128

1.31

7.69

1.1

292.11

426.58

mg/l

0.48

470

1927

Other retinal disorders

258

1420

1.46

7.66

1.1

298.84

288.64

mg/l

1.29

233

1256

Other and unspecified effects of external causes

148

903

1.65

7.66

1.0

1.1

284.11

286.94

mg/l

0.18

136

815

Transport accidents

221

1306

1.50

7.63

1.1

285.82

287.04

mg/l

0.09

199

1190

Acute alcohol intoxication, ICD10

109

613

1.79

7.59

1.0

1.1

287.70

280.91

mg/l

0.45

101

561

Pneumonia, organism unspecified

434

2353

1.34

7.47

1.1

299.78

413.53

mg/l

0.43

395

2107

Problems related to lifestyle

289

2.16

7.45

1.1

271.86

283.12

mg/l

0.59

262

Nonorganic sleeping disorders, excluding more controls

487

1.88

7.44

1.1

1.0

290.82

290.23

mg/l

0.02

450

Acute sinusitis

267

1734

1.44

7.43

1.1

291.07

289.52

mg/l

0.13

248

1554

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

115

600

1.75

7.40

1.1

279.46

282.33

mg/l

0.14

104

553

Other maternal disorders predominantly related to pregnancy

281

1231

1.44

7.35

1.1

306.13

545.29

mg/l

0.49

253

1098

Dental pulpitis 4

535

2134

1.30

7.33

1.1

291.98

426.33

mg/l

0.48

470

1931

Dental pulpitis 1

535

2135

1.30

7.32

1.1

292.19

426.25

mg/l

0.48

470

1932

Other disorders of teeth and supporting structures

101

562

1.81

7.30

1.1

1.0

293.70

286.49

mg/l

0.42

508

Other diseases of pleura

170

959

1.57

7.26

1.0

309.79

285.56

mg/l

2.44

151

851

Enlarged lymph nodes

393

1.97

7.26

1.1

1.0

311.04

285.61

mg/l

1.33

348

Senile cataract

273

1176

1.44

7.25

1.1

285.07

541.60

mg/l

0.51

234

1057

Type 1 diabetes, wide definition

111

636

1.75

7.24

1.2

1.1

317.06

281.77

mg/l

3.74

577

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

180

906

1.55

7.11

1.1

1.0

294.79

286.71

mg/l

0.63

162

812

Undetermined asthma, excluding more controls

301

2.10

7.10

1.1

291.54

286.97

mg/l

0.18

265

Heart failure and coronary heart disease

106

444

1.78

7.06

1.0

316.24

287.04

mg/l

3.07

100

388

Propionic acid derivatives

153

468

1.65

7.05

1.1

287.42

292.15

mg/l

0.22

139

425

Kela-code for severe mental illness

189

1247

1.52

7.03

1.1

287.39

284.82

mg/l

0.19

170

1125

Deposits [accretions] on teeth

181

2.42

7.01

1.2

1.1

271.80

285.96

mg/l

0.52

166

Fracture of shoulder and upper arm

162

1034

1.57

6.97

1.1

301.96

285.39

mg/l

2.01

144

937

Spondylopathies (FG)

435

1.90

6.93

1.1

286.43

284.09

mg/l

0.10

394

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

475

2564

1.30

6.88

1.1

298.41

403.84

mg/l

0.44

435

2297

Injury, poisoning and certain other consequences of external causes

290

1024

1.42

6.86

1.0

1.1

293.39

290.36

mg/l

0.24

262

920

Exclusions for E4_PCOS_BROAD

517

1.81

6.77

1.1

1.0

308.92

286.44

mg/l

1.76

468

Cardiomyopathy (excluding other)

294

2.09

6.76

1.0

1.1

305.11

272.16

mg/l

2.38

270

Vitamin B12 deficiency anaemia

210

2.30

6.75

1.1

1.0

294.77

289.45

mg/l

0.16

182

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

158

1013

1.57

6.72

1.0

1.1

305.54

291.61

mg/l

1.49

149

902

Acetic acid derivatives and related substances

133

413

1.68

6.70

1.1

294.48

296.27

mg/l

0.07

115

373

Streptococcal septicaemia

186

2.38

6.70

1.1

1.0

291.03

283.19

mg/l

0.28

166

Unspecified haematuria

165

911

1.56

6.69

1.1

287.34

285.71

mg/l

0.09

147

816

Disturbances of skin sensation

139

867

1.61

6.65

1.1

285.67

291.67

mg/l

0.53

129

780

Paralytic ileus and intestinal obstruction

565

1.76

6.60

1.1

1.0

292.25

291.04

mg/l

0.06

512

Inflammatory diseases of female pelvic organs

274

1471

1.41

6.60

1.0

1.1

308.13

507.21

mg/l

0.48

246

1306

Undetermined asthma

312

2.03

6.49

1.1

291.54

288.07

mg/l

0.13

275

Other metabolic disorders

333

1.99

6.48

1.1

1.0

309.62

290.40

mg/l

0.61

305

Disorders of choroid and retina

340

1831

1.35

6.48

1.1

296.21

452.20

mg/l

0.47

309

1625

Benign neoplasm: Stomach

227

2.22

6.47

1.0

290.70

291.81

mg/l

0.04

200

Crohn's disease of large intestine

141

2.58

6.46

1.0

1.1

293.23

287.20

mg/l

0.15

128

Benign neoplasm: Stomach

228

2.21

6.40

1.0

290.70

290.09

mg/l

0.02

203

Other abnormal uterine and vaginal bleeding

101

411

1.76

6.39

1.0

293.40

1031.72

mg/l

0.51

366

Ischaemic heart disease, wide definition

341

1577

1.36

6.39

1.0

1.1

287.54

477.36

mg/l

0.50

303

1401

Impingement syndrome of shoulder

118

715

1.66

6.36

1.0

1.1

2792.07

285.35

mg/l

0.50

106

641

Hypotension

308

2.02

6.35

1.1

1.0

294.15

286.66

mg/l

0.27

273

Injuries to the shoulder and upper arm

383

2435

1.32

6.31

1.1

296.72

409.08

mg/l

0.45

330

2195

Migraine with aura

118

719

1.65

6.23

1.1

290.85

295.57

mg/l

0.27

113

657

Fissure and fistula of anal and rectal regions

109

651

1.68

6.21

1.1

1.0

293.07

288.05

mg/l

0.20

584

Special screening examination for other diseases and disorders

187

2.31

6.16

1.0

286.45

284.86

mg/l

0.05

168

Dental caries 1 and operation codes

407

1585

1.32

6.14

1.1

285.06

289.70

mg/l

0.62

365

1418

Migraine without aura

103

608

1.70

6.14

1.1

287.53

294.14

mg/l

0.41

555

Benign neoplasm: Caecum

213

2.22

6.13

1.0

285.17

288.13

mg/l

0.10

188

Acute gastritis

163

2.41

6.11

1.1

1.0

292.03

285.94

mg/l

0.24

145

Dental operations

305

1138

1.38

6.11

1.0

1.1

285.72

291.94

mg/l

0.70

273

1021

Sub-endpoint used in defining T1D endpoints

141

888

1.57

6.06

1.1

309.34

281.84

mg/l

3.12

124

804

Carpal tunnel syndrome

271

1777

1.38

6.01

1.0

1.1

295.94

292.37

mg/l

0.36

237

1583

Early onset COPD

105

627

1.68

6.01

1.0

1.1

304.30

283.00

mg/l

2.10

558

Benign neoplasm: Caecum

215

2.20

6.00

1.0

285.18

288.78

mg/l

0.13

186

Disorders of synovium and tendon

236

1509

1.41

6.00

1.1

294.68

290.89

mg/l

0.32

207

1366

Hard cardiovascular diseases

344

1652

1.34

5.99

1.0

295.16

468.82

mg/l

0.47

310

1465

Injuries to the thorax

187

1275

1.47

5.99

1.0

1.1

280.02

284.61

mg/l

0.41

167

1144

Atopic dermatitis

279

1737

1.37

5.98

1.1

302.60

287.24

mg/l

2.52

252

1565

Urticaria and erythema

176

1187

1.49

5.97

1.2

1.1

286.66

292.11

mg/l

0.43

157

1071

Other acute lower respiratory infections

233

1581

1.41

5.92

1.1

296.38

287.26

mg/l

1.02

203

1424

Dental pulpitis 4, only avohilmo

534

2206

1.27

5.91

1.1

291.59

422.30

mg/l

0.48

477

1988

Malignant neoplasm of digestive organs

130

811

1.58

5.85

1.1

1.0

303.52

286.45

mg/l

1.41

115

724

Dental pulpitis 1, only avohilmo

535

2215

1.26

5.83

1.1

291.82

421.68

mg/l

0.48

477

1997

Sarcoidosis

376

1.87

5.77

1.0

314.09

286.37

mg/l

2.25

342

Neuromuscular dysfunction of bladder

219

2.16

5.75

1.0

304.48

288.36

mg/l

0.76

199

Cervicalgia

537

1.72

5.74

1.1

287.33

289.46

mg/l

0.11

480

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

226

2.14

5.72

1.0

287.75

291.18

mg/l

0.11

206

Fenamates

258

1.89

5.70

1.1

1.0

288.27

300.67

mg/l

0.86

233

Emotionally unstable personality disorder

378

1.86

5.68

1.1

303.90

293.35

mg/l

0.53

349

Voice disturbances

115

714

1.62

5.68

1.1

290.85

293.85

mg/l

0.17

103

641

Anti-inflammatory and antirheumatic products, non-steroids

146

468

1.57

5.67

1.0

1.1

290.79

292.15

mg/l

0.05

133

425

Visual disturbances and blindness

216

1531

1.41

5.65

1.1

293.44

290.36

mg/l

0.25

195

1376

Ovarian cyst

167

641

1.51

5.62

1.1

307.19

768.03

mg/l

0.49

145

574

Postmenopausal bleeding

120

404

1.64

5.61

1.1

1.0

298.34

1048.62

mg/l

0.50

104

357

Provisional assignment of new diseases of uncertain etiology

202

1418

1.43

5.58

1.0

1.1

300.89

288.57

mg/l

1.50

170

1282

Ischemic heart diseases

340

1608

1.33

5.58

1.0

1.1

286.88

474.01

mg/l

0.50

304

1426

Restless leg syndrome

310

1.95

5.57

1.1

1.0

288.59

293.48

mg/l

0.20

278

Urticaria

146

963

1.52

5.55

1.3

1.1

287.70

291.76

mg/l

0.25

130

864

Codes for special purposes

202

1420

1.43

5.54

1.0

1.1

300.89

288.66

mg/l

1.48

170

1284

Pacemaker

101

593

1.66

5.53

1.0

307.84

284.80

mg/l

2.34

527

Other predominantly sexually transmitted diseases, not elsewhere classified

559

1.69

5.51

1.1

284.10

289.31

mg/l

0.28

510

STROKE

251

1262

1.38

5.48

1.1

287.00

525.36

mg/l

0.50

230

1122

Tumor necrosis factor alpha inhibitors

463

1.76

5.48

1.1

270.66

285.35

mg/l

1.22

422

DVT of lower extremities

427

1.79

5.44

1.0

294.96

287.91

mg/l

0.38

388

Dental caries 3 and operation codes

419

1669

1.29

5.43

1.1

284.47

289.48

mg/l

0.71

379

1496

Peripheral artery disease

149

793

1.52

5.42

1.1

1.0

300.55

285.85

mg/l

1.26

126

715

Atherosclerosis, excluding cerebral and coronary sclerosis

134

692

1.55

5.41

1.1

1.0

305.17

285.82

mg/l

1.78

113

623

Calcific aortic valvular stenosis

505

1.71

5.40

1.0

308.43

286.91

mg/l

1.68

448

Calcific aortic valvular stenosis, operated

505

1.71

5.40

1.0

308.43

286.91

mg/l

1.68

448

Calcific aortic valvular stenosis, diagnosis (helper)

505

1.71

5.40

1.0

308.43

286.91

mg/l

1.68

448

Operations 2 for CAVS

505

1.71

5.40

1.0

308.43

286.91

mg/l

1.68

448

Ulcerative rectosigmoiditis

245

2.06

5.40

1.0

1.1

278.09

285.45

mg/l

0.28

223

Injuries to the abdomen, lower back, lumbar spine and pelvis

162

1091

1.48

5.39

1.1

1.0

288.76

286.11

mg/l

0.16

145

977

Diseases of the ear and mastoid process

590

2416

1.24

5.39

1.1

290.14

290.09

mg/l

0.01

528

2178

Other and unspecified drugs and medicaments

212

2.14

5.38

1.0

288.70

291.04

mg/l

0.07

190

Other problems related to primary support group, including family circumstances

340

1.87

5.38

1.0

1.1

4714.03

291.04

mg/l

0.49

306

Calcific aortic valvular stenosis, including rheumatic fever

506

1.71

5.35

1.0

308.43

286.83

mg/l

1.69

449

Fracture of lower leg, including ankle

245

1784

1.37

5.35

1.1

286.14

288.52

mg/l

0.17

222

1605

Mixed and other personality disorders

246

2.05

5.34

1.1

299.11

285.93

mg/l

0.90

225

Pruritus

280

1.98

5.34

1.1

1.0

311.58

291.52

mg/l

1.00

252

Endometriosis

158

625

1.51

5.32

1.1

299.82

781.80

mg/l

0.51

145

558

Diseases of the myoneural junction and muscle

309

1.92

5.29

1.0

276.25

286.30

mg/l

0.39

277

Thyroiditis, ILD-related definition

295

1.94

5.29

1.1

1.0

325.43

292.24

mg/l

1.63

271

Other respiratory diseases principally affecting the interstitium

359

1.85

5.26

1.0

296.62

284.08

mg/l

0.75

317

Fracture of lumbar spine and pelvis

469

1.73

5.22

1.1

1.0

290.92

287.54

mg/l

0.14

420

Diabetic neuropathy

380

1.82

5.21

1.0

1.1

298.92

279.40

mg/l

1.12

338

Mental and behavioural disorders due to tobacco

236

2.05

5.15

1.0

1.1

289.31

285.46

mg/l

0.13

216

Disturbance of activity and attention

322

1.88

5.13

1.1

276.53

282.47

mg/l

0.25

297

Peripheral arterial reconstruction

305

1.91

5.13

1.0

319.54

283.54

mg/l

2.19

268

Rotator cuff syndrome

261

1433

1.36

5.13

1.0

1.1

1416.56

289.80

mg/l

0.50

236

1288

Intestinal stricture

119

765

1.56

5.11

1.1

1.0

291.74

286.77

mg/l

0.32

105

685

Assault

451

1.74

5.10

1.1

286.48

280.11

mg/l

0.32

412

ILD, hospital admissions

313

1.89

5.10

1.0

293.83

285.29

mg/l

0.42

275

Superficial injury of lower leg

115

735

1.57

5.08

1.0

1.1

292.73

288.79

mg/l

0.26

662

Trigger finger

371

1.81

5.06

1.0

1.1

302.39

285.74

mg/l

0.92

331

ILD, hospital admissions 1, main diag only

286

1.93

5.05

1.0

293.18

284.66

mg/l

0.38

251

Valvular heart disease excluding rheumatic fever

184

939

1.43

5.04

1.1

304.42

282.48

mg/l

3.35

166

845

Non-rheumatic valve diseases

183

932

1.44

5.04

1.1

304.25

282.47

mg/l

3.28

165

838

Diseases of external ear

142

953

1.49

5.01

1.0

1.1

292.47

287.31

mg/l

0.36

124

858

Other or unspecified ileus, impaction or obstruction

372

1.81

5.01

1.1

1.0

288.88

289.39

mg/l

0.02

335

Other interstitial pulmonary diseases

315

1.88

5.00

1.0

293.83

285.59

mg/l

0.40

277

Coronary atherosclerosis

282

1361

1.34

5.00

1.0

1.1

293.76

285.94

mg/l

0.94

250

1209

UC patients in KELA-register (code 208), prior to 1994

123

2.47

4.97

1.1

1.0

303.40

285.73

mg/l

0.53

111

Hernia

436

2350

1.26

4.97

1.1

290.94

414.89

mg/l

0.49

388

2114

Thyrotoxicosis, other and/or unspecified

515

1.68

4.95

1.0

1.1

306.67

295.17

mg/l

0.73

463

Smoking dependency

240

2.01

4.94

1.0

1.1

289.31

284.95

mg/l

0.16

221

Covid-19 confirmed case

121

788

1.54

4.93

1.0

1.1

300.03

286.25

mg/l

1.17

104

716

Cerebral palsy and other paralytic syndromes

317

1.87

4.92

1.1

1.0

295.46

289.14

mg/l

0.24

285

Interstitial lung disease

317

1.87

4.92

1.0

293.83

285.33

mg/l

0.41

279

Interstitial lung disease endpoints

317

1.87

4.92

1.0

293.83

285.33

mg/l

0.41

279

Chronic rhinitis, nasopharyngitis and pharyngitis

144

974

1.48

4.90

1.0

1.1

294.00

290.63

mg/l

0.18

124

890

Excessive attrition of teeth

184

696

1.44

4.86

1.0

1.1

288.61

706.68

mg/l

0.50

163

634

Persistent mood disorders

518

1.67

4.85

1.0

1.1

290.71

290.36

mg/l

0.02

463

Subjective visual disturbances

104

658

1.59

4.82

1.1

288.80

290.89

mg/l

0.11

588

Cramp and spasm

125

2.42

4.81

1.2

1.0

289.90

291.95

mg/l

0.04

111

AV-block

271

1.88

4.71

1.0

316.98

280.03

mg/l

2.43

244

Exclusions for E4_PCOS_CONSORTIUM

337

1635

1.29

4.71

1.1

298.92

478.23

mg/l

0.49

302

1468

Disorders of skin appendages

221

1628

1.36

4.66

1.1

294.64

288.26

mg/l

0.46

197

1467

COPD (mode)

110

560

1.56

4.65

1.0

1.1

312.27

284.01

mg/l

3.13

489

DVT of lower extremities and pulmonary embolism

151

1039

1.45

4.65

1.1

1.0

303.97

288.31

mg/l

1.72

136

927

Enterocolitis due to Clostridium difficile

232

1.99

4.63

1.0

299.88

292.93

mg/l

0.26

205

Sleep disorders

106

681

1.56

4.62

1.1

288.18

286.84

mg/l

0.05

623

Asthma, hospital admissions 3, pneumonia

137

928

1.48

4.62

1.1

307.73

287.95

mg/l

1.45

123

833

Asthma-related pneumonia or sepsis

137

928

1.48

4.62

1.1

307.73

287.95

mg/l

1.45

123

833

Other arthritis (FG)

133

898

1.49

4.60

1.1

297.61

288.73

mg/l

0.79

128

803

Disorders resulting from impaired renal tubular function

2.71

4.60

1.0

269.78

283.76

mg/l

0.42

Lumbar disc prolapse

278

1681

1.32

4.59

1.1

285.91

467.47

mg/l

0.52

254

1515

Hyperkinetic disorders

358

1.77

4.52

1.1

276.84

281.76

mg/l

0.21

330

Ventral hernia

606

1.59

4.52

1.0

285.82

287.34

mg/l

0.08

551

Adverse effects, not elsewhere classified

575

1.61

4.52

1.1

1.0

284.05

293.34

mg/l

0.68

518

Polyuria

521

1.64

4.51

1.1

279.13

288.68

mg/l

0.52

471

Other and unspecified urticaria

591

1.60

4.51

1.3

1.1

285.41

291.59

mg/l

0.29

535

Fracture of foot, except ankle

117

773

1.52

4.51

1.1

283.14

284.85

mg/l

0.09

108

697

Asthma-related pneumonia

136

927

1.47

4.46

1.1

308.37

287.93

mg/l

1.51

122

832

Inflammatory diseases of prostate (prostatitis)

343

1.79

4.44

1.0

256.40

278.10

mg/l

1.96

312

Umbilical hernia

119

792

1.51

4.43

1.1

1.0

289.98

280.62

mg/l

0.65

104

723

Atopic dermatitis, strict definition with reimbursement

151

1021

1.44

4.42

1.0

1.1

295.59

288.81

mg/l

0.49

141

924

Sulfasalazine

123

825

1.50

4.41

1.0

1.1

282.32

287.00

mg/l

0.33

111

739

Vitreous haemorrhage

258

1.91

4.39

1.1

1.0

307.50

285.15

mg/l

1.23

233

Disorders of psychological development

373

1.72

4.38

1.1

279.28

281.85

mg/l

0.09

340

Other disorders of bone

612

1.57

4.36

1.1

288.86

287.10

mg/l

0.05

559

Amputation

197

2.04

4.32

1.1

1.0

311.15

284.16

mg/l

0.85

178

Dental caries 1

351

1407

1.28

4.31

1.0

1.1

288.14

290.53

mg/l

0.23

315

1263

Other enthesopathies

132

903

1.47

4.30

1.0

1.1

2539.31

290.68

mg/l

0.49

118

809

Thyrotoxicosis

107

701

1.53

4.30

1.0

1.1

302.51

296.27

mg/l

0.38

626

Dental caries, including avohilmo

350

1404

1.28

4.28

1.0

1.1

288.32

290.59

mg/l

0.22

314

1260

Injuries to the wrist and hand

458

2704

1.23

4.28

1.1

949.53

290.16

mg/l

0.50

404

2442

Benign neoplasm: Rectum

407

1.70

4.26

1.0

288.39

285.24

mg/l

0.11

365

Enthesopathies of lower limb, excluding foot

100

648

1.55

4.23

1.1

289.44

290.56

mg/l

0.05

577

Abnormal findings on diagnostic imaging of central nervous system

108

2.43

4.23

1.3

1.0

264.12

290.74

mg/l

0.87

Epilepsy

129

880

1.47

4.21

1.1

281.64

285.86

mg/l

0.26

118

791

Other complications of surgical and medical care, not elsewhere classified

262

1.88

4.21

1.1

1.0

313.90

294.88

mg/l

0.95

236

Visual disturbances

196

1444

1.36

4.20

1.1

290.17

290.68

mg/l

0.03

176

1297

Dental caries 3

371

1503

1.26

4.19

1.1

285.26

290.34

mg/l

0.63

334

1353

Delirium, not induced by alcohol and other psychoactive substances

213

1.98

4.18

1.1

1.0

273.47

289.38

mg/l

0.73

190

Eating disorder

220

1.96

4.18

1.1

1.0

292.61

301.94

mg/l

0.30

206

Misadventures to patients during surgical and medical care

372

1.73

4.18

1.1

1.0

298.85

291.82

mg/l

0.28

334

Noninflammatory disorders of female genital tract

184

666

1.39

4.08

1.1

302.33

749.75

mg/l

0.50

165

598

Other and unspecified nonorganic psychotic disorders

104

686

1.52

4.08

1.1

291.00

283.21

mg/l

0.49

627

Benign neoplasm: Rectum, anus and anal canal

459

1.64

4.05

1.0

300.02

287.28

mg/l

0.43

412

Diseases of middle ear and mastoid

266

1681

1.30

4.04

1.1

1367.22

286.61

mg/l

0.50

247

1514

Acute bronchitis

162

1141

1.39

4.04

1.1

295.82

287.73

mg/l

0.64

138

1021

Cerebrovascular diseases

285

1586

1.29

4.04

1.1

1.0

289.86

289.25

mg/l

0.05

258

1411

Metatarsalgia

231

1.91

4.00

1.0

294.51

292.34

mg/l

0.07

207

Heartburn

217

1.94

4.00

1.0

277.56

291.29

mg/l

0.89

192

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

2.49

3.97

1.0

316.76

292.65

mg/l

0.58

Congenital malformations, deformations and chromosomal abnormalities

280

2095

1.28

3.96

1.1

289.57

289.42

mg/l

0.01

249

1893

Deviated nasal septum

141

995

1.42

3.92

1.0

1.1

275.40

283.61

mg/l

0.75

124

905

Mycoses

110

741

1.49

3.92

1.1

1.0

296.83

287.16

mg/l

0.63

658

Migraine without aura and triptan purchases

495

1.60

3.90

1.1

285.08

299.39

mg/l

0.95

448

Adjustment and management of implanted device

335

1.74

3.89

1.1

1.0

316.96

285.86

mg/l

1.79

304

Disorders of parathyroid gland

458

1.62

3.89

1.1

1.0

301.03

294.93

mg/l

0.33

402

Diseases of salivary glands

528

1.58

3.85

1.1

1.0

296.31

290.50

mg/l

0.26

477

Paroxysmal tachycardia

464

1.57

3.83

1.0

1.1

283.73

285.95

mg/l

0.09

424

Internal derangement of knee

167

1216

1.37

3.83

1.1

291.84

288.34

mg/l

0.22

142

1090

Psychotic depression

139

2.17

3.83

1.1

290.33

292.44

mg/l

0.06

131

Other medical care

144

1001

1.41

3.82

1.1

298.99

290.06

mg/l

0.78

125

894

Conduction disorders

101

556

1.51

3.81

1.0

1.1

301.52

285.73

mg/l

1.26

503

Benign neoplasm: Rectum

421

1.65

3.80

1.0

288.39

288.20

mg/l

0.01

375

Other arthrosis

225

1223

1.32

3.78

1.0

1.1

287.82

532.75

mg/l

0.50

190

1092

Procreative management

167

1028

1.37

3.76

1.2

1.1

300.40

287.34

mg/l

0.81

144

928

Benign neoplasm: Rectum, anus and anal canal

469

1.60

3.75

1.0

300.02

287.88

mg/l

0.40

421

Other arrhythmias

269

1608

1.28

3.73

1.1

1416.00

288.39

mg/l

0.50

235

1451

Other disorders of patella

564

1.55

3.73

1.1

293.62

290.91

mg/l

0.14

506

Nonorganic sleeping disorders

597

1.53

3.70

1.1

290.82

288.71

mg/l

0.07

546

Superficial injury of head

637

1.51

3.70

1.1

1.0

286.93

286.35

mg/l

0.03

567

COPD

157

938

1.38

3.69

1.0

302.82

286.81

mg/l

1.79

137

828

Other enthesopathy of foot (+metatarsalgia)

254

1.82

3.62

1.0

295.34

292.11

mg/l

0.11

229

Unspecified fall

195

1461

1.33

3.60

1.1

290.97

287.13

mg/l

0.21

178

1311

Chondropathies

483

1.58

3.57

1.1

288.24

288.08

mg/l

0.00

440

Adalimumab

285

1.76

3.56

1.1

1.0

269.81

288.92

mg/l

1.34

254

Other contact dermatitis

234

1.85

3.55

1.0

314.47

289.56

mg/l

0.87

209

Agranulocytosis

285

1.76

3.55

1.1

1.0

336.09

290.19

mg/l

1.50

257

Metabolic disorder, other/unspecified

10.48

3.54

1.7

1.0

229.00

288.33

mg/l

—

Paracetamol of NSAID medication

304

1.54

3.53

1.1

284.04

283.12

mg/l

0.03

279

Cervical disc disorders

146

1059

1.38

3.52

1.1

277.69

569.34

mg/l

0.53

133

951

Oter anti-inflammatory and antirheumatic agents, non-steroids

297

1.57

3.52

1.0

286.14

303.12

mg/l

1.25

268

Dental caries 3, only avohilmo

374

1552

1.23

3.52

1.1

286.43

290.12

mg/l

0.41

335

1392

Parodontitis or/and operation codes

302

1427

1.26

3.51

1.1

292.79

495.75

mg/l

0.49

263

1285

Colonic or urogenital fistula

117

817

1.44

3.51

1.1

1.0

292.44

286.89

mg/l

0.23

738

Other female pelvic inflammatory diseases

423

1.61

3.50

1.0

1.1

298.93

300.40

mg/l

0.07

373

Osteoporosis

500

1.55

3.49

1.1

1.0

308.73

297.06

mg/l

0.70

439

Otitis externa

631

1.49

3.46

1.0

1.1

295.00

285.01

mg/l

0.66

568

Personal history of other diseases and conditions

316

1.71

3.45

1.1

1.0

287.69

293.94

mg/l

0.26

286

Lichen ruber planus, wide definition including periferal and oral lichen planus

567

1.52

3.45

1.1

1.0

284.18

290.06

mg/l

0.33

505

Dental operations, only avohilmo

305

1243

1.26

3.43

1.0

1.1

288.06

290.82

mg/l

0.25

272

1111

Other specified/unspecified arthritis

111

772

1.44

3.41

1.1

302.25

290.01

mg/l

1.14

106

688

Eating disorders

296

1.73

3.40

1.1

1.0

302.39

295.04

mg/l

0.24

272

Dental pulpitis 2, only avohilmo

316

1294

1.25

3.39

1.0

1.1

286.58

289.68

mg/l

0.30

284

1159

Dental pulpitis 2

309

1263

1.25

3.39

1.0

1.1

287.67

289.37

mg/l

0.15

279

1132

COPD related to multimorbidity

123

732

1.42

3.38

1.0

300.30

285.12

mg/l

1.46

105

654

Fracture of rib(s), sternum and thoracic spine

112

782

1.44

3.38

1.0

276.83

282.06

mg/l

0.36

101

697

Moderate visual impairment, binocular

3.12

3.37

1.0

303.23

289.03

mg/l

0.32

Other chronic obstructive pulmonary disease

148

898

1.37

3.37

1.0

305.05

286.66

mg/l

2.11

128

791

Superficial injury of thorax

412

1.61

3.36

1.0

290.67

286.95

mg/l

0.15

370

Other viral diseases

140

1015

1.38

3.35

1.1

303.55

284.85

mg/l

1.13

128

920

Missing teeth due to accident, extraction or parodontitis

283

1.74

3.35

1.1

299.47

289.69

mg/l

0.39

254

Peripheral artery operations in Hilmo

246

1.79

3.34

1.1

1.0

308.13

283.98

mg/l

0.88

221

Temporomandibular joint disorders

405

1.61

3.34

1.1

303.29

292.79

mg/l

0.37

364

Polymyalgia rheumatica

239

1.81

3.34

1.0

315.35

288.21

mg/l

1.38

204

Malignant neoplasm, wide definition for exclusion

409

1998

1.21

3.33

1.1

297.19

436.04

mg/l

0.46

367

1797

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

409

1998

1.21

3.33

1.1

297.19

436.04

mg/l

0.46

367

1797

Schizophrenia or delusion

149

1098

1.36

3.29

1.1

288.15

283.54

mg/l

0.33

137

986

Other pleural conditions

212

1.85

3.26

1.0

308.00

286.27

mg/l

0.94

183

Schizophrenia, schizotypal and delusional disorders

149

1100

1.36

3.26

1.1

288.15

283.44

mg/l

0.34

137

988

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

408

2000

1.21

3.22

1.1

297.15

435.84

mg/l

0.46

366

1799

Candidiasis

355

1.64

3.21

1.1

1.0

292.76

289.61

mg/l

0.11

320

Temporomandibular joint disorders, including avohilmo

184

1402

1.31

3.21

1.0

1.1

292.44

296.36

mg/l

0.26

161

1264

Convalescence

130

2.09

3.18

1.0

290.68

286.31

mg/l

0.11

120

Other spirochaetal diseases

105

735

1.43

3.15

1.1

1.0

296.05

289.90

mg/l

0.33

654

Other specified and unspecified personality disorders

281

1.72

3.15

1.1

1.0

303.02

289.47

mg/l

0.62

256

Other disorders of lacrimal gland

136

996

1.37

3.14

1.1

302.53

294.23

mg/l

0.51

120

887

Mixed specific developmental disorders

2.58

3.13

1.2

1.1

271.29

289.89

mg/l

0.35

Fall on and from stairs and steps

101

704

1.44

3.11

1.0

1.1

294.94

287.67

mg/l

0.56

635

Disorders of lacrimal system

164

1238

1.33

3.11

1.1

300.23

294.37

mg/l

0.39

146

1097

Assault by bodily force

245

1.77

3.11

1.0

1.1

279.45

277.67

mg/l

0.05

222

Carcinoma in situ of skin of trunk

3.10

3.09

1.0

307.50

303.32

mg/l

0.05

Oral lichen ruber planus wide, hypothyreosis or thyroxin

112

2.16

3.07

1.1

1.0

287.92

291.91

mg/l

0.11

Allergic asthma (mode), excluding more controls

103

709

1.43

3.06

1.0

1.1

292.34

284.21

mg/l

0.56

644

Blood alcohol or alcohol intoxication level

2.61

3.05

1.1

293.63

268.16

mg/l

0.76

Hyperparathyroidism

379

1.59

3.04

1.1

1.0

297.06

293.09

mg/l

0.17

335

Lyme disease

103

724

1.43

3.04

1.1

1.0

294.16

289.12

mg/l

0.26

645

Hypermobility syndrome

126

2.08

3.02

1.1

261.19

303.96

mg/l

2.45

113

Congenital malformations and deformations of the musculoskeletal system

261

1.72

3.01

1.1

290.88

286.70

mg/l

0.07

237

Childhood asthma (age<16), excluding more controls

334

1.57

3.00

1.1

289.33

275.66

mg/l

0.42

304

Venous thromboembolism

192

1445

1.29

2.99

1.1

1.0

304.68

288.34

mg/l

2.32

169

1292

Disorders of sclera, cornea, iris and ciliary body

223

1763

1.27

2.99

1.1

291.26

288.14

mg/l

0.28

201

1582

Dental caries 1, only avohilmo

347

1460

1.22

2.93

1.1

287.78

290.17

mg/l

0.23

311

1308

Mental and behavioural disorders due to opioids

121

2.08

2.93

1.1

312.68

269.03

mg/l

2.03

108

Insomnia

500

1.51

2.92

1.1

288.83

287.95

mg/l

0.03

454

Vasomotor and allergic rhinitis

167

1258

1.31

2.91

1.0

1.1

295.55

290.70

mg/l

0.38

146

1151

All influenza

698

1.42

2.89

1.3

1.1

286.41

282.51

mg/l

0.20

629

Acute suppurative otitis media

128

879

1.36

2.89

1.1

295.66

283.01

mg/l

0.78

118

807

Allergic asthma (mode)

103

718

1.41

2.88

1.0

1.1

292.34

284.64

mg/l

0.52

652

Diabetic retinopathy, excluding more controls

138

572

1.36

2.88

1.0

1.1

299.75

280.15

mg/l

2.01

123

503

Childhood asthma (age<16)

338

1.55

2.87

1.1

289.33

277.28

mg/l

0.36

309

Alzheimer disease

336

0.49

2.86

1.0

285.44

294.50

mg/l

0.23

292

Suppurative and unspecified otitis media

167

1134

1.31

2.84

1.1

292.65

285.47

mg/l

0.47

156

1030

Disorders of eyelid, lacrimal system and orbit

345

2249

1.20

2.83

1.1

293.15

424.42

mg/l

0.49

309

2015

Diabetes mellitus in pregnancy

142

685

1.35

2.83

1.0

1.1

315.18

305.18

mg/l

0.77

130

627

Haemolytic anaemias

2.36

2.82

1.1

1.0

296.94

283.47

mg/l

0.25

Degeneration of macula and posterior pole

138

848

1.34

2.82

1.1

1.0

292.92

293.60

mg/l

0.04

125

735

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

456

1.52

2.81

1.0

1.1

315.44

301.71

mg/l

0.77

408

Dermatopolymyositis (FG)

3.27

2.78

1.0

1.1

304.00

283.76

mg/l

—

Benign neoplasm: Connective and other soft tissue of thorax

8.56

2.77

1.2

319.20

241.67

mg/l

—

Other disorders of carbohydrate metabolism

8.53

2.76

1.0

1.2

241.40

261.00

mg/l

—

Atopic dermatitis, strict definition

142

1050

1.33

2.75

1.0

1.1

295.81

290.04

mg/l

0.38

134

958

Pollen allergy

641

1.42

2.73

1.1

290.14

287.70

mg/l

0.12

593

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

127

934

1.35

2.71

1.0

1.1

2560.17

293.44

mg/l

0.49

117

849

Benign neoplasm: Pancreas

2.62

2.71

1.0

292.86

296.41

mg/l

0.06

Spinal stenosis

176

1070

1.29

2.70

1.1

292.12

569.26

mg/l

0.50

152

955

Volume depletion

153

1.90

2.70

1.1

1.0

322.55

289.17

mg/l

0.96

130

Non-allergic asthma (mode), excluding more controls

472

1.49

2.69

1.0

1.1

314.05

284.15

mg/l

1.28

420

Any event in cancer register

418

2100

1.18

2.68

1.1

297.96

429.91

mg/l

0.46

373

1890

Fall on same level involving ice and snow

227

1826

1.24

2.67

1.1

299.54

287.90

mg/l

1.15

203

1625

Retention of urine

106

647

1.39

2.67

1.1

290.79

286.56

mg/l

0.23

587

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

161

1.87

2.66

1.1

1.0

329.30

289.16

mg/l

1.56

139

Triptan medication for migraine, min. 3 purchases

257

1649

1.23

2.66

1.1

293.04

296.68

mg/l

0.36

237

1485

Disorders of vestibular function (Vertigo)

166

1278

1.29

2.65

1.1

1.0

289.89

293.38

mg/l

0.27

144

1138

Other degenerative diseases of the nervous system

434

1.45

2.65

1.0

275.68

295.01

mg/l

1.77

387

Other diseases of blood and blood-forming organs

183

1.81

2.65

1.0

309.78

285.63

mg/l

0.96

164

COPD, early/later onset

148

951

1.32

2.65

1.0

305.05

286.38

mg/l

2.21

128

844

Diseases of appendix

333

2537

1.20

2.64

1.1

292.22

405.79

mg/l

0.48

301

2282

Pre-eclampsia or eclampsia

661

1.41

2.63

1.1

291.86

304.72

mg/l

0.94

581

Benign neoplasm: Ascending colon

281

1.64

2.63

1.0

290.34

285.90

mg/l

0.18

253

Diabetic nephropathy

531

1.46

2.60

1.1

327.75

281.39

mg/l

5.18

472

Major coronary heart disease event excluding revascularizations

231

1283

1.24

2.59

1.0

1.1

293.08

284.91

mg/l

0.85

209

1141

Other sleep disorders

275

1.64

2.58

1.1

278.47

285.92

mg/l

0.29

247

Lichen planus, including avohilmo

482

1.48

2.57

1.1

1.0

287.12

290.30

mg/l

0.13

431

Disorders of phosphorus metabolism and phosphatases

7.32

2.56

1.0

1.1

271.00

310.86

mg/l

—

Other salmonella infections

2.14

2.55

1.1

1.0

315.60

282.78

mg/l

1.22

Medical abortion

256

1130

1.23

2.54

1.1

306.92

302.25

mg/l

0.42

225

1000

Diseases of male genital organs

253

1037

1.24

2.53

1.1

270.76

274.24

mg/l

0.34

229

950

Diabetic nephropathy, excluding more controls

443

1.46

2.53

1.1

329.36

281.03

mg/l

5.50

387

Localized swelling, mass and lump of skin and subcutaneous tissue

120

896

1.34

2.53

1.1

1.0

294.41

289.06

mg/l

0.34

111

803

Fracture of skull and facial bones

667

1.40

2.52

1.1

275.28

281.97

mg/l

0.40

598

Striking against or struck by other objects

148

1140

1.30

2.50

1.1

281.01

281.00

mg/l

0.00

131

1035

COPD, hospital admissions

146

950

1.30

2.46

1.0

304.85

286.29

mg/l

2.16

127

842

Benign neoplasm: Pancreas

2.48

2.46

1.0

292.86

279.56

mg/l

0.27

Non-allergic asthma (mode)

484

1.46

2.42

1.0

1.1

314.05

284.91

mg/l

1.23

433

Appendicitis, broad definition

328

2528

1.19

2.41

1.1

292.35

406.09

mg/l

0.48

297

2275

Myocardial infarction, without ST-elevation

113

778

1.34

2.38

1.0

304.51

285.49

mg/l

1.62

100

693

Alzheimer disease, including avohilmo

384

0.58

2.37

1.0

297.24

292.84

mg/l

0.12

333

Other inflammation of eyelid

345

1.54

2.37

1.1

1.0

291.01

292.20

mg/l

0.04

310

Superficial injury of wrist and hand

633

1.39

2.37

1.1

297.29

284.25

mg/l

0.98

583

Endometriosis of ovary

457

1.47

2.36

1.0

1.1

301.46

303.04

mg/l

0.07

409

Rheumatoid arthritis

122

838

1.33

2.36

1.0

1.1

293.50

651.34

mg/l

0.50

108

742

Benign neoplasm: Sigmoid colon

426

1.48

2.36

1.0

1.1

276.32

285.48

mg/l

0.60

378

Other embolism and thrombosis

314

1.57

2.34

1.1

1.0

301.43

292.86

mg/l

0.33

282

Other and unspecified nerve root and plexus disorders, also in other diseases

559

1.42

2.34

1.2

1.0

292.45

283.79

mg/l

0.61

504

Triptan medication for migraine, single purchase ok

367

2115

1.18

2.33

1.1

286.93

432.05

mg/l

0.52

334

1902

Migraine, single triptan purchase ok & required. ICD-code if available is included

367

2115

1.18

2.33

1.1

286.93

432.05

mg/l

0.52

334

1902

Persons encountering health services in circumstances related to reproduction

279

1572

1.20

2.32

1.1

292.66

475.40

mg/l

0.48

250

1419

Burns and corrosions

422

1.47

2.26

1.0

1.1

283.19

mg/l

0.00

386

Cardiodefibrillation

112

843

1.33

2.25

1.0

2856.75

284.36

mg/l

0.50

104

748

Viral and other specified intestinal infections

657

1.37

2.25

1.2

1.1

297.84

283.19

mg/l

0.87

593

Oral lichen ruber planus, hypothyreosis or thyroxin

3.14

2.23

1.0

1.1

288.56

281.92

mg/l

—

Dental caries 2 and operation codes

346

2343

1.17

2.23

1.1

285.02

416.38

mg/l

0.53

301

2120

Benign neoplasm of mouth and pharynx

271

1.59

2.22

1.0

1.1

294.24

289.23

mg/l

0.17

245

Tongue abnormality

150

1.81

2.20

1.1

1.0

282.41

286.29

mg/l

0.07

129

COPD, hospital admissions 1, only main diagnosis

101

639

1.35

2.20

1.0

311.48

283.88

mg/l

3.01

572

Benign neoplasm: Sigmoid colon

433

1.46

2.19

1.0

276.32

286.54

mg/l

0.69

386

Car occupant injured in other and unspecified transport accidents

609

1.38

2.18

1.0

1.1

281.03

287.34

mg/l

0.36

551

Colectomy operation

409

1.47

2.18

1.1

1.0

297.06

288.07

mg/l

0.35

371

Diseases of inner ear

193

1532

1.23

2.18

1.1

290.05

291.26

mg/l

0.09

167

1364

Haemorrhage in early pregnancy

112

829

1.32

2.17

1.1

299.62

303.53

mg/l

0.23

100

736

Malignant neoplasm

395

2017

1.16

2.16

1.1

300.28

434.53

mg/l

0.44

350

1814

Flatulence and related conditions

4.34

2.16

1.0

1.1

275.33

292.93

mg/l

—

Monoamine oxidase A inhibitors

297

1.55

2.16

1.2

1.0

289.68

288.25

mg/l

0.06

273

Open wound of lower leg

386

1.48

2.15

1.0

1.1

292.58

284.95

mg/l

0.32

348

Contraceptive management

201

1148

1.23

2.15

1.1

297.27

548.95

mg/l

0.49

184

1040

Insulin, fast-acting (human)

452

1.44

2.14

1.2

1.1

332.34

281.67

mg/l

3.63

413

Lichen planus

338

1.51

2.13

1.0

282.83

292.76

mg/l

0.46

302

Tonsillectomy and adenotomy

275

1606

1.19

2.13

1.1

290.19

289.14

mg/l

0.08

251

1453

Tic and related disorders

3.23

2.10

1.1

1.2

266.88

286.89

mg/l

—

Haemorrhoids and perianal venous thrombosis

656

1.36

2.09

1.1

1.0

281.63

291.07

mg/l

0.79

585

Primary_lymphoid and hematopoietic malignant neoplasms

555

1.39

2.08

1.1

314.90

287.86

mg/l

1.89

494

Dentofacial anomalies [including malocclusion]

114

864

1.31

2.07

1.1

292.12

290.18

mg/l

0.09

103

780

COPD-related respiratory insufficiency

237

1.61

2.07

1.1

1.0

296.87

285.49

mg/l

0.52

208

Etanercept

191

1.68

2.06

1.1

275.85

293.25

mg/l

0.71

172

Disorders of vitreous body and globe

173

1362

1.24

2.06

1.1

301.61

512.88

mg/l

0.47

145

1207

Complications predominantly related to the puerperium

104

788

1.32

2.05

1.0

1.1

298.73

302.57

mg/l

0.22

695

Superficial injury of hip and thigh

341

1.50

2.05

1.1

1.0

283.58

289.62

mg/l

0.22

302

Pre-eclampsia

617

1.36

2.04

1.1

294.60

305.15

mg/l

0.66

543

358

1.48

2.04

1.0

1.1

316.45

288.30

mg/l

0.73

319

Burns and corrosions of external body surface, specified by site

326

1.51

2.03

1.0

1.1

288.91

283.56

mg/l

0.18

296

Carcinoma in situ of skin of trunk

2.42

2.03

1.0

307.50

290.30

mg/l

0.26

Contact with machinery

318

1.52

2.03

1.1

273.45

278.13

mg/l

0.23

291

Tobacco use

147

1.78

2.02

1.1

1.0

273.32

283.88

mg/l

0.30

134

Diffuse brain injury

2.12

2.02

1.1

276.94

281.54

mg/l

0.07

Oral leukoplakia and related diseases, including avohilmo

231

1.61

2.02

1.1

1.0

294.72

288.00

mg/l

0.19

204

Other bullous disorders

2.24

2.01

1.0

273.21

287.78

mg/l

0.24

Need for other prophylactic measures

140

1.80

2.01

1.1

1.0

324.96

281.71

mg/l

0.80

124

Pulmonary heart disease, diseases of pulmonary circulation

100

756

1.32

2.01

1.1

1.0

311.95

287.47

mg/l

2.43

677

Diseases of tongue

155

1.75

2.00

1.1

282.41

293.11

mg/l

0.23

137

Deforming dorsopathies

106

809

1.31

2.00

1.1

302.91

291.11

mg/l

0.54

720

Cervicobrachial syndrome

645

1.35

2.00

1.1

279.10

291.72

mg/l

1.15

576

Disorders of vitreous body

168

1329

1.24

1.99

1.1

300.60

518.11

mg/l

0.47

141

1178

Other respiratory disorders and diseases

426

1.43

1.98

1.1

1.0

313.64

285.67

mg/l

1.78

382

Other diseases of the respiratory system

426

1.43

1.98

1.1

1.0

313.64

285.67

mg/l

1.78

382

Other disorders of veins

140

1109

1.26

1.97

1.0

1.1

305.07

294.92

mg/l

0.84

115

996

Stroke, excluding SAH

201

1227

1.22

1.97

1.1

288.55

289.86

mg/l

0.09

178

1093

Contact with and exposure to communicable diseases

1165

0.75

1.96

1.1

286.35

289.83

mg/l

0.17

1067

Carcinoma in situ of skin of ear and external auricular canal

4.58

1.94

1.2

1.0

302.60

295.27

mg/l

—

Filling of root of tooth

2.02

1.91

1.1

1.0

261.06

286.39

mg/l

1.20

Other otitis externa (chronic)

173

1.68

1.89

1.1

1.0

316.30

289.04

mg/l

1.15

157

Motor disorders, excluding more controls

2.71

1.89

1.0

1.2

262.89

268.73

mg/l

—

Myocardial infarction

170

990

1.23

1.89

1.0

1.1

295.96

283.14

mg/l

1.29

155

881

severe traumatic brain injury, does not include concussion

515

1.38

1.88

1.1

1.0

270.65

282.26

mg/l

0.75

460

Benign neoplasm: other/unspecified salivary gland

0.00

1.88

0.0

1.0

—

295.02

—

Arthrosis

304

1427

1.17

1.88

1.0

1.1

279.81

497.79

mg/l

0.53

261

1281

LSIL lesion of the vagina

2.68

1.87

1.0

1.1

312.67

291.66

mg/l

—

Other cataract

147

911

1.25

1.87

1.0

1.1

286.44

291.50

mg/l

0.39

131

815

Pregnancy with abortive outcome

258

1136

1.19

1.86

1.1

303.05

302.10

mg/l

0.07

226

1006

Mouth breathing

164

1333

1.23

1.86

1.0

1.1

293.10

283.69

mg/l

0.87

149

1203

Dental caries 2

347

2364

1.15

1.85

1.1

284.53

415.38

mg/l

0.53

302

2139

Benign neoplasm: Ascending colon

309

1.49

1.85

1.0

290.34

285.23

mg/l

0.22

273

Polyarthrosis

472

1.38

1.82

1.0

1.1

280.91

293.76

mg/l

0.74

413

Thyrotoxicosis with toxic multinodular goitre

123

1.80

1.0

298.95

294.44

mg/l

0.12

102

Tic disorders

2.79

1.80

1.1

1.0

266.88

301.52

mg/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

572

1.35

1.78

1.1

314.90

286.14

mg/l

2.09

509

Viral infections characterized by skin and mucous membrane lesions

164

1341

1.22

1.77

1.1

294.82

286.26

mg/l

0.50

153

1205

Phlebitis and thrombophlebitis (not including DVT)

581

1.35

1.77

1.1

1.0

302.91

290.10

mg/l

0.85

525

Pain associated with micturition

288

1.50

1.76

1.0

278.74

295.15

mg/l

0.82

260

Ethmoidectomy

387

1.43

1.76

1.2

1.1

271.26

287.16

mg/l

1.10

351

Hypoparathyroidism

2.04

1.75

1.0

321.67

289.48

mg/l

1.08

Spondylosis

193

1376

1.20

1.75

1.1

284.33

507.26

mg/l

0.52

171

1237

Rheumatoid arthritis, including avohilmo

137

1102

1.25

1.74

1.0

1.1

292.59

293.89

mg/l

0.07

122

979

Benign neoplasm: Pituitary gland, craniopharyngeal duct

132

1.75

1.74

1.1

1.0

308.52

285.45

mg/l

0.68

120

Motor disorders

2.51

1.73

1.0

1.1

262.89

313.13

mg/l

—

Sequelae of cerebrovascular disease

656

1.30

1.72

1.0

294.07

286.96

mg/l

0.45

583

Pain in thoracic spine

423

1.40

1.71

1.0

1.1

271.27

288.30

mg/l

1.36

380

Oxicams

343

1.34

1.71

1.1

1.0

275.17

298.29

mg/l

2.07

309

Asthma/COPD (KELA code 203)

406

2523

1.13

1.70

1.1

294.29

405.56

mg/l

0.47

359

2270

Other and unspecified tonsillitis

153

1058

1.23

1.70

1.1

290.45

282.52

mg/l

0.43

136

966

Appendectomy

279

2315

1.16

1.70

1.0

1.1

294.12

290.17

mg/l

0.39

247

2086

Nonsuppurative otitis media

663

1.29

1.69

1.1

297.10

284.64

mg/l

0.76

601

Other neurological diseases

257

1767

1.17

1.69

1.1

283.04

291.38

mg/l

1.14

230

1573

Major coronary heart disease event

248

1408

1.18

1.68

1.0

1.1

295.31

285.79

mg/l

1.10

225

1247

Need for immunization against other single viral diseases

2.20

1.68

1.2

1.0

307.17

281.33

mg/l

0.44

Soft tissue disorders related to use, overuse and pressure

735

1.29

1.68

1.1

287.85

287.11

mg/l

0.04

657

Pre-eclampsia or poor fetal growth

119

945

1.26

1.67

1.1

291.14

305.36

mg/l

1.36

109

836

COPD, hospital admission 2, with asthma infections

596

1.30

1.66

1.0

1.1

314.25

284.32

mg/l

2.93

534

Kyphosis

2.83

1.65

1.0

1.1

294.86

284.90

mg/l

—

Pregnancy examination and test

316

1.37

1.64

1.1

303.09

320.23

mg/l

0.91

283

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

159

1308

1.22

1.63

1.1

291.44

287.49

mg/l

0.27

147

1184

Other maltreatment syndromes

105

1.82

1.63

1.1

292.84

278.53

mg/l

0.31

All influenza (not pneumonia)

444

1.38

1.63

1.3

1.1

283.17

284.16

mg/l

0.03

400

Disorders of conjunctiva

344

2526

1.14

1.62

1.1

294.37

407.89

mg/l

0.48

307

2271

Tic and related disorders

2.52

1.60

1.1

1.0

266.88

302.00

mg/l

—

Benign neoplasm of mouth and pharynx

295

1.46

1.60

1.0

1.1

294.24

288.92

mg/l

0.18

267

Benign neoplasm: Pituitary gland, craniopharyngeal duct

136

1.70

1.59

1.1

1.0

308.52

290.81

mg/l

0.47

121

Pregnancy hypertension

164

1226

1.21

1.57

1.1

293.72

304.31

mg/l

1.01

152

1086

Lesion of lateral popliteal nerve

129

1.71

1.57

1.2

1.1

288.64

286.35

mg/l

0.05

117

Other abnormal findings of blood chemistry

1.86

1.56

1.1

1.0

283.82

286.21

mg/l

0.05

Acute appendicitis

298

2452

1.15

1.56

1.1

291.03

409.17

mg/l

0.49

268

2212

Gestational diabetes (for exclusion)

148

858

1.22

1.56

1.0

1.1

301.48

304.34

mg/l

0.20

133

778

Other obstetric conditions, not elsewhere classified

128

670

1.24

1.55

1.0

1.1

301.29

306.19

mg/l

0.29

122

607

Unstable angina pectoris

108

710

1.26

1.55

1.1

291.72

284.86

mg/l

0.41

626

104

774

1.27

1.55

1.0

302.16

292.55

mg/l

0.71

676

Stroke, including SAH

212

1331

1.18

1.54

1.1

288.63

290.28

mg/l

0.12

189

1187

Endometriosis ASRM stages 3,4

657

1.30

1.54

1.0

1.1

297.50

299.81

mg/l

0.12

586

Pericarditis

1.84

1.52

1.0

313.24

275.74

mg/l

1.17

Unspecific neurodegenerative disorder

479

0.72

1.52

1.0

292.21

288.94

mg/l

0.11

416

Speech therapy

747

1.27

1.51

1.1

1.0

304.34

288.98

mg/l

1.32

673

Supplementary factors related to causes of morbidity and mortality classified elsewhere

117

943

1.24

1.51

1.1

293.47

285.19

mg/l

0.47

108

855

Bullous disorders

123

1.71

1.51

1.0

282.57

292.71

mg/l

0.24

109

All dysplastic lesions of the vagina

2.08

1.49

1.0

1.1

300.83

297.56

mg/l

0.08

Other chronic obstructive pulmonary disease, including avohilmo

173

1206

1.19

1.48

1.0

1.1

2061.72

286.69

mg/l

0.50

151

1075

Retinal detachments and breaks

109

875

1.25

1.47

1.1

292.63

287.02

mg/l

0.35

100

777

Specific developmental disorder of motor function

2.41

1.47

1.0

1.1

262.89

311.75

mg/l

—

Superficial injury of abdomen, lower back and pelvis

402

1.37

1.46

1.1

285.84

286.78

mg/l

0.03

363

Vitamin D deficiency

2.39

1.46

1.0

1.1

281.67

287.67

mg/l

—

Dental pulpitis 3

312

1.36

1.46

1.1

1.2

309.38

288.04

mg/l

0.69

286

Eustachian salpingitis and obstruction

252

1.47

1.45

1.1

279.72

277.48

mg/l

0.07

233

Complications of internal orthopaedic prosthetic devices, implants and grafts

506

1.33

1.45

1.0

298.30

289.79

mg/l

0.42

451

Superficial injury of shoulder and upper arm

310

1.42

1.45

1.0

300.33

283.96

mg/l

0.74

282

Special screening examination for neoplasms

1.88

1.44

1.0

255.10

295.04

mg/l

—

Dental caries 2 and operation codes, only avohilmo

316

1723

1.14

1.44

1.1

284.46

460.77

mg/l

0.52

274

1559

Other benign neoplasms of skin

123

984

1.23

1.44

1.1

1.0

294.98

288.88

mg/l

0.27

103

876

Angina pectoris

205

1179

1.18

1.43

1.1

289.23

285.44

mg/l

0.29

185

1047

Dermatographic urticaria

180

1.56

1.42

1.1

279.86

293.56

mg/l

0.49

162

Keratitis

134

1104

1.22

1.42

1.1

293.67

286.61

mg/l

0.53

122

993

Bronchitis, not specified as acute or chronic

237

1.48

1.41

1.1

287.86

285.13

mg/l

0.10

217

Dental caries 2, only avohilmo

335

2338

1.13

1.41

1.1

284.30

416.69

mg/l

0.53

293

2113

Injuries to the neck

721

1.26

1.39

1.0

288.62

286.57

mg/l

0.09

655

Unspecified acute lower respiratory infection

432

1.35

1.39

1.1

301.22

279.71

mg/l

1.25

396

Impacted cerumen

230

1.48

1.38

1.0

289.56

291.78

mg/l

0.05

206

Other peripheral vascular diseases

198

1.52

1.37

1.1

1.0

311.56

293.90

mg/l

0.53

180

Organic, including symptomatic, mental disorders

131

778

1.22

1.36

1.1

1.0

289.23

292.00

mg/l

0.16

111

692

Other abortion

2.97

1.36

1.0

1.1

278.40

292.35

mg/l

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

2.96

1.36

1.2

1.1

369.20

333.00

mg/l

—

Undescended testicle

0.00

1.35

0.0

1.1

—

296.55

—

Allergic urticaria

224

1.48

1.33

1.2

1.0

294.61

294.53

mg/l

0.00

202

Benign neoplasm: Tongue

1.98

1.33

1.1

1.0

288.67

282.07

mg/l

0.12

Use of anticholinesterases

406

0.70

1.32

1.0

288.18

293.16

mg/l

0.13

354

N06DA Anticholinesterases

406

0.70

1.32

1.0

288.18

293.16

mg/l

0.13

354

Actinic keratosis

672

1.26

1.32

1.0

302.56

292.68

mg/l

0.66

584

Diabetic retinopathy

157

832

1.19

1.32

1.0

1.1

300.77

284.98

mg/l

1.64

140

730

Diabetic retinopathy, strict definition

598

1.27

1.32

1.0

1.1

313.13

283.90

mg/l

2.34

530

Vestibular neuronitis

233

1.46

1.31

1.1

1.0

287.75

288.81

mg/l

0.03

211

Focal epilepsy, strict definition

515

1.30

1.1

283.35

283.88

mg/l

0.02

459

Leiomyoma of uterus

189

908

1.17

1.30

1.1

298.35

628.50

mg/l

0.50

169

812

Peritonsillar abscess

675

1.26

1.29

1.1

291.56

284.47

mg/l

0.35

621

FESS (DNB20)

378

1.35

1.28

1.2

1.1

267.98

288.70

mg/l

1.54

343

Fentanyl

177

1.53

1.28

1.1

1.0

318.64

293.74

mg/l

0.77

155

Carrier of infectious disease

2.06

1.27

1.0

279.78

290.82

mg/l

—

Leiomyoma of uterus

236

1168

1.15

1.26

1.1

299.20

562.52

mg/l

0.51

212

1030

Redundant prepuce, phimosis and paraphimosis

719

1.25

1.26

1.2

1.1

268.48

271.34

mg/l

0.18

660

Pathological resorption of teeth

1.83

1.25

1.1

249.29

286.24

mg/l

1.69

Deep endometriosis

228

1.45

1.24

1.1

1.0

295.29

293.59

mg/l

0.05

200

Effects of foreign body entering through natural orifice

796

1.23

1.24

1.0

1.1

275.04

280.36

mg/l

0.32

722

Conjunctivitis

311

2417

1.12

1.21

1.1

296.37

413.90

mg/l

0.47

281

2173

Benign paroxysmal vertigo

717

1.24

1.21

1.0

294.18

292.02

mg/l

0.12

643

Sequelae of injuries, of poisoning and of other consequences of external causes

753

1.24

1.21

1.1

1.0

296.42

282.87

mg/l

1.16

682

Open wound of wrist and hand

178

1518

1.16

1.19

1.1

282.59

280.52

mg/l

0.14

157

1379

Abscess of anal and rectal regions

230

1.44

1.19

1.1

1.0

315.25

285.70

mg/l

0.46

208

Malignant neoplasm of rectosigmoid junction

2.32

1.19

1.0

237.83

292.33

mg/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

121

652

1.21

1.18

1.0

1.1

299.42

306.16

mg/l

0.42

115

589

Aortic aneurysm

454

1.30

1.18

1.0

290.06

279.53

mg/l

0.47

417

Gonarthrosis

253

1277

1.14

1.17

1.0

1.1

282.71

523.39

mg/l

0.52

214

1145

Other benign neoplasms of skin

123

1029

1.20

1.17

1.1

294.98

290.79

mg/l

0.17

103

918

Use of glatiramer acetate

2.02

1.17

1.2

1.1

259.60

290.60

mg/l

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.00

1.15

0.0

1.0

—

290.80

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.00

1.15

0.0

1.0

—

290.80

—

Seropositive rheumatoid arthritis

667

1.24

1.15

1.0

1.1

297.01

292.50

mg/l

0.20

600

Calculus of kidney and ureter

813

1.22

1.14

1.1

274.35

282.76

mg/l

0.62

733

Ischaemic Stroke, excluding all haemorrhages

174

1133

1.16

1.14

1.1

1.0

285.36

290.22

mg/l

0.40

155

1011

Nasal polyp

528

1.27

1.12

1.0

1.1

292.74

282.75

mg/l

0.57

479

Spondylolisthesis/Spondylolysis

475

1.29

1.12

1.1

290.18

289.54

mg/l

0.02

425

Other and unspecified epidermal thickening

1.97

1.11

1.0

1.1

304.60

287.43

mg/l

—

Benign leiomyoma with endometriosis

397

1.31

1.10

1.1

1.0

297.65

300.37

mg/l

0.11

349

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

123

954

0.84

1.10

1.1

313.45

612.21

mg/l

0.47

106

852

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

123

954

0.84

1.10

1.1

313.45

612.21

mg/l

0.47

106

852

Polyarthritis, unspecified

1.67

1.10

1.2

1.0

271.56

292.98

mg/l

0.51

Hypertrophy of breast

521

1.27

1.10

1.2

1.0

293.80

300.31

mg/l

0.40

459

Allergic rhinitis

134

1127

1.18

1.09

1.1

291.88

289.00

mg/l

0.18

118

1027

Operations for atrial fibrillation

1.97

1.09

1.0

320.13

292.72

mg/l

—

Carcinoma in situ of breast, intraductal

219

0.59

1.09

1.0

324.29

295.19

mg/l

—

191

Pulmonary embolism

701

1.23

1.08

1.1

1.0

313.79

285.45

mg/l

2.63

628

Salpingitis and oophoritis

514

1.27

1.07

1.0

1.1

290.61

298.31

mg/l

0.44

451

Pulmonary heart disease

702

1.23

1.07

1.1

1.0

313.79

285.74

mg/l

2.59

628

Inguinal hernia

181

1401

0.87

1.07

1.1

273.51

279.59

mg/l

0.60

165

1278

Endometriosis of pelvic peritoneum

464

1.28

1.06

1.1

309.49

305.82

mg/l

0.15

417

Coronary artery bypass grafting

451

1.25

1.06

1.0

300.80

283.72

mg/l

0.92

398

Gonarthrosis [arthrosis of knee](FG)

294

1550

1.12

1.05

1.0

1.1

286.03

481.44

mg/l

0.52

250

1395

Single delivery by caesarean section

373

1.24

1.04

1.1

299.39

318.40

mg/l

1.13

333

Achilles tendinitis

297

1.35

1.04

1.1

1.0

284.59

284.38

mg/l

0.01

274

Hypertrophy of breast in women and men

624

1.24

1.04

1.2

1.0

292.28

297.41

mg/l

0.33

555

Benign leiomyoma with endometriosis

402

1.30

1.03

1.1

1.0

297.65

302.07

mg/l

0.19

356

Fitting and adjustment of other devices

724

1.21

1.02

1.1

1.0

283.84

290.98

mg/l

0.48

642

Viral pneumonia

333

1.32

1.01

1.1

317.44

287.40

mg/l

0.66

300

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

530

0.75

1.01

1.1

1.0

314.06

288.05

mg/l

1.47

476

Benign neoplasm: Tongue

1.77

1.00

1.1

1.0

288.67

298.29

mg/l

0.19

Complications of the puerperium, not elsewhere classified

1.62

1.00

1.1

293.88

304.23

mg/l

0.25

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

175

1338

1.15

0.99

1.1

293.05

529.37

mg/l

0.53

162

1181

Skin changes due to chronic exposure to nonionizing radiation

713

1.21

0.99

1.0

303.02

292.49

mg/l

0.74

620

Paraplegia, diplegia of upper limbs

1.85

0.99

1.0

311.22

281.31

mg/l

—

Use of other anti-dementia drugs

289

0.69

0.97

1.0

289.35

294.90

mg/l

0.13

248

Use of memantine

289

0.69

0.97

1.0

289.35

294.90

mg/l

0.13

248

Embolic stroke

1.67

0.97

1.0

324.86

286.51

mg/l

1.16

Acute laryngitis and tracheitis

409

1.28

0.96

1.1

274.40

277.14

mg/l

0.11

372

Acute appendicitis, no complications

230

2050

1.12

0.95

1.1

295.02

288.16

mg/l

0.80

211

1845

Injuries to the elbow and forearm

270

2199

1.11

0.94

1.0

1.1

295.07

424.03

mg/l

0.47

247

1966

Other disorders of cornea

251

1.36

0.93

1.0

292.97

288.94

mg/l

0.16

226

Dependence on enabling machines and devices, not elsewhere classified

2.23

0.93

1.0

259.83

302.00

mg/l

—

Hydrocele

303

1.32

0.93

1.1

271.00

275.78

mg/l

0.17

279

Other bursopathies

312

1.32

0.93

1.0

310.19

283.99

mg/l

1.44

280

Hypoglycaemia, other or unspecified

175

1.43

0.92

1.1

1.0

305.08

288.55

mg/l

0.46

157

Artrosis, including avohilmo

366

1834

1.10

0.92

1.0

1.1

283.47

291.16

mg/l

1.07

320

1665

Erythema multiforme

1.74

0.92

1.0

289.56

292.71

mg/l

—

Meniscus derangement

215

1309

1.12

0.92

1.0

1.1

286.95

516.53

mg/l

0.51

192

1172

Dislocation, sprain and strain of joints and ligaments at neck level

472

1.25

0.92

1.0

290.17

288.34

mg/l

0.06

424

Focal epilepsy

571

1.23

0.91

1.1

1.0

284.59

283.76

mg/l

0.03

511

Injury of muscle and tendon at shoulder and upper arm level

120

1030

1.17

0.91

1.1

1.0

294.11

281.40

mg/l

1.03

102

940

Myocardial infarction, strict

148

939

1.15

0.91

1.0

1.1

300.46

282.97

mg/l

1.83

134

835

Primary open-angle glaucoma

615

0.79

0.90

1.0

297.57

291.91

mg/l

0.23

544

Allergic purpura

1.70

0.89

1.1

1.0

317.17

291.81

mg/l

0.48

Allergic colitis

1.87

0.87

1.0

1.1

246.75

289.71

mg/l

—

Follicular cysts of skin and subcutaneous tissue

530

1.23

0.87

1.1

1.0

294.60

282.35

mg/l

0.67

476

Hyperkinetic disorders (excl. ADHD)

1.78

0.86

1.0

1.1

297.60

291.50

mg/l

—

Dental pulpitis 3, only avohilmo

288

1.27

0.85

1.1

1.2

316.40

287.63

mg/l

0.96

263

Delivery

108

668

0.85

1.1

289.58

313.07

mg/l

3.59

581

Acute bronchiolitis

153

1.41

0.84

1.1

300.25

288.91

mg/l

0.31

140

Other crystal arthropathies

1.88

0.82

1.0

1.1

288.33

311.07

mg/l

—

Multiple delivery

249

0.68

0.82

1.1

285.82

315.58

mg/l

1.09

212

Male infertility

177

0.62

0.81

1.0

1.1

264.64

268.68

mg/l

0.08

165

Foreign body entering into or through eye or natural orifice

241

1.33

0.80

1.1

281.59

281.37

mg/l

0.01

217

Delivery, wide proxy

530

0.84

0.80

1.1

296.30

314.85

mg/l

1.52

462

Postmenopausal atrophic vaginitis

420

1.19

0.78

1.1

1.0

307.97

1017.25

mg/l

0.49

373

Open wound of hip and thigh

0.52

0.78

1.2

1.0

236.80

271.14

mg/l

—

Papillary adenocarcinoma of thyroid gland

126

0.55

0.77

1.1

1.0

290.29

292.01

mg/l

—

108

Conductive and sensorineural hearing loss

285

1805

1.09

0.77

1.1

290.87

454.94

mg/l

0.50

255

1615

Carcinoma in situ of breast, intraductal

198

0.66

0.76

1.0

324.29

295.50

mg/l

—

170

Trochanteric bursitis

305

1.28

0.76

1.1

304.32

291.24

mg/l

0.70

274

Acute nasopharyngitis (common cold)

419

1.24

0.76

1.0

281.47

274.38

mg/l

0.37

381

Benign neoplasm: Skin of trunk

1.52

0.75

1.0

341.27

286.91

mg/l

0.47

Puerperal sepsis

350

1.26

0.75

1.0

1.1

279.05

300.14

mg/l

1.59

305

Oesophageal obstruction

1.65

0.75

1.0

278.45

297.58

mg/l

0.43

Coxarthrosis, primary, with hip surgery

100

1095

0.86

0.74

1.1

290.43

292.06

mg/l

0.09

966

Malignant neoplasm of prostate

623

0.85

0.74

1.0

1.1

286.82

279.02

mg/l

0.56

566

Other disorders of breast

324

1.27

0.74

1.0

309.26

297.05

mg/l

0.42

288

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

201

1.35

0.74

1.1

1.0

289.59

299.36

mg/l

0.41

182

Scissor bite

1.60

0.74

1.1

256.17

288.94

mg/l

1.08

Malignant neoplasm of breast

136

1111

0.88

0.74

1.1

1.0

316.84

572.17

mg/l

0.46

116

983

Dental caries 3 and operation codes, only avohilmo

135

595

1.14

0.73

1.0

1.1

294.99

284.22

mg/l

0.71

120

530

Unspecified nephritic syndrome

1.64

0.73

1.1

1.0

267.56

281.38

mg/l

—

Gonarthrosis, primary, with knee surgery

139

1282

0.88

0.73

1.1

281.20

526.14

mg/l

0.53

113

1139

Glaucoma

132

1312

0.88

0.73

1.0

1.1

298.23

291.25

mg/l

0.57

118

1162

Supervision of high-risk pregnancy

414

1.18

0.73

1.1

293.89

315.31

mg/l

1.88

378

Urolithiasis

101

875

1.16

0.72

1.1

274.09

282.67

mg/l

0.65

789

Focal epilepsy, mode (most common among epilepsy diagnosis)

506

1.21

0.72

1.1

283.19

284.22

mg/l

0.03

450

Long labour

686

0.84

0.71

1.0

1.1

306.02

306.66

mg/l

0.02

614

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

778

0.85

0.71

1.1

1.0

319.90

683.14

mg/l

0.46

692

Disorders of refraction and accommodation

878

0.85

0.71

1.0

1.1

281.29

288.84

mg/l

0.40

797

Obstructed labour due to malposition and malpresentation of fetus

708

0.84

0.70

1.1

294.33

307.78

mg/l

1.19

642

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

701

1.17

0.70

1.0

1.1

296.39

292.38

mg/l

0.17

626

Any dementia

446

0.82

0.70

1.0

290.18

292.63

mg/l

0.08

394

Other/unspecified seropositive rheumatoid arthritis

711

1.17

0.70

1.0

1.1

297.01

292.66

mg/l

0.19

634

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

203

1.33

0.69

1.0

286.09

281.59

mg/l

0.14

178

Malignant neoplasm of breast, HER-positive

930

0.86

0.69

1.1

1.0

320.36

627.99

mg/l

0.46

813

Allergic contact dermatitis due to drugs in contact with skin

1.67

0.68

1.1

1.0

293.29

300.35

mg/l

—

Postpartum haemorrhage due to anatomy

275

1.27

0.68

1.1

294.68

296.77

mg/l

0.07

257

Mental and behavioural disorders due to use of other stimulants, including caffeine

102

1.48

0.67

1.0

1.1

291.93

276.58

mg/l

0.60

Outcome of delivery

343

1.19

0.67

1.0

1.1

306.28

316.26

mg/l

0.51

310

Benign neoplasm: Vagina

1.79

0.66

1.0

1.1

288.00

287.83

mg/l

—

Malignant neoplasm of breast, HER2-negative

132

1090

0.89

0.66

1.1

1.0

317.52

577.35

mg/l

0.46

112

963

Covid-19 suspected case

697

1.16

0.65

1.0

1.1

304.06

288.16

mg/l

1.01

639

Female infertility, cervigal, vaginal, other or unspecified origin

577

1.15

0.65

1.0

1.1

288.98

816.62

mg/l

0.52

519

Alzheimer disease, excluding more controls

159

0.71

0.65

1.0

273.50

300.41

mg/l

0.72

140

Other disorders of bone density and structure

1.62

0.65

1.0

274.80

293.59

mg/l

—

Presence of other functional implants

167

1066

1.11

0.64

1.1

297.54

290.36

mg/l

0.62

148

932

Gestational [pregnancy-induced] hypertension

790

1.15

0.64

1.1

285.33

304.75

mg/l

1.65

694

Fracture at wrist and hand level

133

1186

1.12

0.64

1.1

287.71

280.36

mg/l

0.60

120

1079

Other disorders of bladder

269

1.27

0.63

1.0

277.93

285.05

mg/l

0.25

242

Single spontaneous delivery

110

665

0.88

0.63

1.0

1.1

290.26

312.96

mg/l

3.47

579

Left ventricular outflow tract obstruction (LVOTO), broad definition

332

1.24

0.63

1.1

319.65

278.65

mg/l

1.85

306

Conjunctivitis (acute, non atopic)

103

903

1.14

0.63

1.1

300.87

288.08

mg/l

0.60

813

Status epilepticus

1.52

0.62

1.1

1.0

283.17

288.96

mg/l

0.08

Benign neoplasm: Skin of other and unspecified parts of face

252

1.27

0.62

1.1

1.0

272.07

291.27

mg/l

1.33

223

Postpartum hemorraghe, parous women as controls

662

1.15

0.62

1.0

1.1

302.18

298.49

mg/l

0.17

605

Chalazion

333

1.23

0.62

1.1

1.0

298.58

290.54

mg/l

0.29

304

Other menopausal disorders

484

0.86

0.61

1.1

298.66

924.18

mg/l

0.51

430

Type of accident

100

880

1.14

0.61

1.1

1.0

289.86

285.77

mg/l

0.17

796

malignant neoplasm of male genital organs

668

0.87

0.61

1.0

1.1

283.64

277.36

mg/l

0.44

608

Flat foot [pes planus] (acquired)

253

1.27

0.61

1.1

1.0

304.17

295.80

mg/l

0.22

221

Dislocation, sprain and strain of joints and ligaments of knee

246

2110

1.08

0.60

1.1

281.95

288.74

mg/l

0.80

221

1911

Seropositive rheumatoid arthritis, wide

722

1.15

0.60

1.0

1.1

297.01

292.62

mg/l

0.20

644

Burns and corrosions confined to eye and internal organs

1.51

0.60

1.1

249.14

280.95

mg/l

—

Superficial injury of forearm

281

1.25

0.59

1.1

1.0

275.80

287.67

mg/l

0.39

252

Short Achilles tendon (acquired)

1.57

0.58

1.1

1.0

296.90

290.14

mg/l

—

Seropositive rheumatoid arthritis, strict definition

421

0.81

0.58

1.0

298.66

290.20

mg/l

0.21

375

Other specific arthropathies, wide

1.51

0.58

1.0

331.50

294.02

mg/l

—

Dementia in Alzheimer disease

188

0.73

0.58

1.0

278.80

294.91

mg/l

—

163

Infectious mononucleosis

264

1.25

0.58

1.1

331.04

286.13

mg/l

1.18

242

Benign neoplasm: Skin of other and unspecified parts of face

255

1.26

0.58

1.1

1.0

272.07

288.08

mg/l

1.03

227

In situ neoplasms

102

861

1.13

0.58

1.0

302.32

293.11

mg/l

0.61

764

Procedures for purposes other than remedying health state

1.49

0.57

1.1

1.0

297.00

297.73

mg/l

—

Respiratory conditions due to other external agents

1.67

0.56

1.0

377.00

292.97

mg/l

—

Labour and delivery complicated by fetal stress [distress]

519

0.86

0.56

1.1

289.65

309.71

mg/l

1.22

473

Pedal cyclist injured in transport accident

710

1.14

0.54

1.0

1.1

288.11

285.80

mg/l

0.12

644

Pregnancy, childbirth and the puerperium

423

0.87

0.54

1.1

296.22

315.44

mg/l

1.14

370

Medicines for HER+ breast cancer

980

0.88

0.54

1.1

1.0

316.36

610.03

mg/l

0.46

858

Primary open-angle glaucoma, strict

524

0.84

0.54

1.0

298.41

293.33

mg/l

0.20

466

Sequelae of external causes of morbidity and mortality

664

1.15

0.54

1.1

1.0

301.04

287.77

mg/l

0.75

590

Carbimazole or st.post thyroidectomy, condition for graves disease

608

1.15

0.53

1.0

308.35

294.14

mg/l

0.90

544

Benign neoplasm: Skin of trunk

108

1.39

0.53

1.0

341.27

287.53

mg/l

0.46

Toxic effect of alcohol

1.52

0.52

1.1

1.0

257.70

274.48

mg/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

462

1.16

0.52

1.0

315.25

282.62

mg/l

2.29

414

Motorcycle rider injured in noncollision transport accidents

0.62

0.52

1.0

1.1

297.33

277.26

mg/l

—

Disorders of puberty

1.50

0.51

1.0

1.1

257.00

304.00

mg/l

—

Epiphora

1.50

0.51

1.0

1.1

277.00

294.32

mg/l

—

Lateral epicondylitis

406

1.18

0.51

1.0

1.1

7104.26

286.34

mg/l

0.49

367

Unknown and unspecified causes of morbidity

179

1.29

0.51

1.0

298.91

287.17

mg/l

0.31

157

Iridocyclitis

677

1.14

0.51

1.1

295.83

285.19

mg/l

0.75

609

Female genital prolapse

503

1.13

0.50

1.0

1.1

292.25

898.84

mg/l

0.51

447

Lichen simplex chronicus

1.42

0.50

1.0

286.62

286.73

mg/l

0.00

Sexual dysfunction

1.47

0.50

1.0

293.33

290.08

mg/l

—

Disorders in reading

1.47

0.50

1.0

1.1

272.17

294.09

mg/l

—

Ectopic pregnancy

528

1.16

0.50

1.0

1.1

324.59

295.65

mg/l

1.64

467

Pedal cyclist injured in other and unspecified transport accidents

325

1.20

0.49

1.1

1.0

295.06

288.23

mg/l

0.23

294

Thoracic aortic aneurysm

325

1.20

0.49

1.1

1.0

273.58

280.86

mg/l

0.27

296

Cystic kidney disease

1.43

0.49

1.2

1.0

302.17

274.71

mg/l

0.49

Haemorrhagic and haematological disorders of fetus and newborn

1.56

0.49

1.0

1.1

317.29

276.79

mg/l

—

Other and unspecified follicular disorders

110

1.37

0.49

1.0

289.07

290.81

mg/l

0.04

100

Autonomic disorders

1.53

0.48

1.1

1.0

331.00

275.74

mg/l

—

Benign neoplasm: Conjunctiva

1.45

0.48

1.0

327.64

280.21

mg/l

0.89

Benign neoplasm: Conjunctiva

1.45

0.48

1.0

327.64

279.59

mg/l

0.90

Malignant neoplasm of other connective and soft tissue

1.49

0.47

1.0

1.1

276.57

280.10

mg/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

177

1284

1.08

0.47

1.0

1.1

307.19

536.50

mg/l

0.49

161

1143

Ganglion

625

1.14

0.47

1.1

296.07

291.57

mg/l

0.19

568

Ulcer of vagina/vulva

1.46

0.47

1.0

280.57

302.21

mg/l

—

Nontoxic goitre/thyroid nodule

805

1.12

0.47

1.1

1.0

292.67

297.88

mg/l

0.33

705

In situ neoplasms

102

919

1.11

0.46

1.0

302.32

295.63

mg/l

0.40

815

Later onset COPD, excluding more controls

269

1.19

0.46

1.0

305.74

280.10

mg/l

1.16

232

Dental caries 1 and operation codes, only avohilmo

112

508

1.11

0.46

1.0

1.1

297.02

284.20

mg/l

0.80

100

451

Embedded and impacted teeth

104

798

1.11

0.45

1.1

290.44

285.13

mg/l

0.24

730

Malignant neoplasm of tongue

1.40

0.45

1.0

298.71

283.20

mg/l

—

Sensorineural hearing loss

258

1695

1.07

0.44

1.1

1.0

292.52

465.38

mg/l

0.49

231

1518

Assault by unspecified means

1.46

0.44

1.0

1.1

297.60

277.56

mg/l

—

Monoarthritis, not elsewhere classified

121

1.33

0.44

1.0

295.94

291.11

mg/l

0.11

109

Melanocytic naevi

885

1.11

0.44

1.0

1.1

298.14

289.37

mg/l

0.56

798

Endometriosis ASRM stages 1,2

535

1.14

0.44

1.1

311.17

298.23

mg/l

0.72

473

Degenerative diseases of the nervous system

427

0.86

0.44

1.0

276.90

291.59

mg/l

0.78

377

Acute appendicitis, with complications

601

1.13

0.43

1.1

1.0

276.25

283.37

mg/l

0.38

548

Medial epicondylitis

1.37

0.43

1.0

1.1

294.77

282.77

mg/l

0.23

Other and unspecified glaucoma

128

0.70

0.43

1.0

317.22

293.21

mg/l

—

112

HSIL lesion of the vagina

1.62

0.43

1.0

1.1

274.20

298.54

mg/l

—

Benign neoplasm of ovary

433

1.16

0.43

1.0

289.98

298.38

mg/l

0.28

388

Primary coxarthrosis, bilateral

639

0.88

0.42

1.1

1.0

291.53

292.79

mg/l

0.05

565

Erythema intertrigo

1.43

0.42

1.0

367.88

276.92

mg/l

—

Bitten or struck by other mammals

331

1.18

0.42

1.0

273.61

294.02

mg/l

0.68

304

Dislocation, sprain and strain of joints and ligaments of head

122

1.31

0.42

1.1

257.25

294.79

mg/l

2.91

108

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.57

0.42

1.2

1.0

266.40

286.85

mg/l

—

Granuloma annulare

1.57

0.42

3.4

1.0

279.20

299.19

mg/l

—

Multiple myeloma

1.57

0.42

1.2

1.0

305.40

308.22

mg/l

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

1.57

0.42

1.2

1.0

305.40

308.22

mg/l

—

Other noninflammatory disorders of uterus, except cervix

378

1.14

0.42

1.0

313.62

1105.04

mg/l

0.49

332

Postpartum hemorraghe, all women as controls

780

1.11

0.42

1.0

1.1

302.18

304.27

mg/l

0.09

703

Female infertility

105

588

1.10

0.42

1.0

1.1

289.75

808.23

mg/l

0.52

528

Anomalies of dental arch relationship, including avohilmo

584

1.12

0.41

1.0

1.1

292.32

289.51

mg/l

0.10

535

Other and unspecified intracranial injuries

1.43

0.41

1.0

301.10

287.11

mg/l

—

Abrasion of teeth

589

1.11

0.41

1.0

1.1

286.20

787.36

mg/l

0.50

535

malignant neoplasm of female genital organs

316

0.82

0.41

1.1

1.0

301.71

299.57

mg/l

0.05

269

Personal history of allergy to drugs, medicaments and biological substances

1.52

0.41

1.2

1.1

364.80

292.39

mg/l

—

Liveborn infants according to place of birth

0.00

0.41

0.0

1.1

—

310.63

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

408

1.15

0.40

1.1

1.0

297.98

287.62

mg/l

0.43

364

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

208

1919

1.07

0.39

1.1

294.30

447.30

mg/l

0.49

184

1727

Sequelae with surgical and medical care as external cause

512

1.13

0.39

1.0

305.17

290.81

mg/l

0.63

460

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.41

0.39

1.1

1.0

290.20

295.47

mg/l

—

Neonatal jaundice from other and unspecified causes

1.43

0.39

1.0

1.1

314.80

284.76

mg/l

—

Mixed conductive and sensorineural hearing loss

297

1.18

0.39

1.1

1.0

280.83

290.59

mg/l

0.37

266

Prolapse and hernia of ovary and fallopian tube

1.42

0.39

1.0

338.00

289.68

mg/l

—

Premature rupture of membranes

508

1.11

0.39

1.1

295.27

311.57

mg/l

1.11

456

Aortic valve malfunction, age under 60 years

307

1.17

0.38

1.1

315.33

280.57

mg/l

1.35

283

Ménière disease

224

1.21

0.38

1.1

1.0

289.96

291.26

mg/l

0.04

200

Other abnormal products of conception

121

742

1.09

0.37

1.1

310.88

302.20

mg/l

0.55

109

671

Seborrhoeic keratosis

524

1.13

0.37

1.1

1.0

285.59

287.04

mg/l

0.06

470

Other epidermal thickening

107

1.31

0.37

1.0

290.71

289.49

mg/l

0.02

Other disorders of Eustachian tube

1.31

0.37

1.3

1.0

286.22

288.93

mg/l

—

Other aneurysm

116

1.30

0.37

1.0

299.73

287.00

mg/l

0.25

106

Other disorders of conjunctiva

355

1.16

0.37

1.0

278.52

292.07

mg/l

0.45

314

Other osteochondropathies

216

1.21

0.36

1.1

255.35

285.16

mg/l

1.81

200

Benign neoplasm of ovary

440

1.14

0.36

1.0

1.1

289.98

298.97

mg/l

0.31

387

Brachial plexus disorders

272

1.18

0.36

1.1

1.0

8609.91

290.34

mg/l

0.49

247

Other malignant neoplasms of skin (=non-melanoma skin cancer)

144

1058

1.07

0.35

1.1

1.0

304.62

290.76

mg/l

1.51

121

942

Volvulus

1.40

0.35

1.0

296.17

298.97

mg/l

—

Keratoconus

1.37

0.34

1.0

297.40

284.91

mg/l

—

Certain conditions originating in the perinatal period

242

1.17

0.34

1.0

1.1

295.63

293.08

mg/l

0.05

222

Coxarthrosis [arthrosis of hip](FG)

173

1174

1.07

0.34

1.1

288.79

542.51

mg/l

0.50

154

1050

Disorders of puberty, all

1.34

0.34

1.0

1.1

257.00

306.64

mg/l

—

Other hearing loss

557

1.11

0.33

1.0

295.44

292.76

mg/l

0.11

501

Melanocytic naevi

903

1.09

0.32

1.0

1.1

298.14

290.02

mg/l

0.51

806

Other and unspecified vascular occlusions

173

1.21

0.32

1.0

310.90

284.91

mg/l

0.88

150

Polycystic ovarian syndrome, broad definition

303

1.16

0.32

1.1

301.48

307.10

mg/l

0.14

277

Coxarthrosis

162

1031

1.07

0.32

1.1

288.63

580.04

mg/l

0.50

145

918

Allergic conjunctivitis

216

2018

1.05

0.31

1.1

293.66

440.44

mg/l

0.50

192

1814

Leisure time condition

503

1.11

0.31

1.1

1.0

275.38

286.27

mg/l

0.53

453

Anterior Iridocyclitis

608

1.10

0.31

1.1

1.0

299.77

285.86

mg/l

1.02

546

Maternal care related to the fetus and amniotic cavity and possible delivery problems

153

958

0.94

0.30

1.0

1.1

299.60

307.36

mg/l

0.68

143

852

Polycythaemia vera

1.34

0.30

1.1

1.0

302.00

283.67

mg/l

—

Acute alcohol intoxication ICD-9

1.34

0.30

1.0

320.70

293.77

mg/l

—

Nontraumatic intracranial haemmorrhage

419

1.12

0.30

1.0

1.1

300.33

286.72

mg/l

0.67

377

Malignant neoplasm of testis

1.25

0.29

1.1

242.57

271.31

mg/l

—

Maternal care for known or suspected malpresentation of fetus

433

1.10

0.29

1.2

1.1

313.22

313.31

mg/l

0.00

390

Malignant melanoma, excluding all cancers (controls excluding all cancers)

382

1.13

0.29

1.1

1.0

290.97

286.05

mg/l

0.17

346

Acute and subacute iridocyclitis

563

1.10

0.29

1.1

1.0

302.25

285.07

mg/l

1.28

508

Labour and delivery complicated by umbilical cord complications

130

1.23

0.28

1.0

288.63

301.56

mg/l

0.27

118

Antepartum haemorrhage, not elsewhere classified

232

1.16

0.28

1.1

305.64

306.04

mg/l

0.01

207

Varicose veins

194

1392

1.05

0.28

1.0

1.1

305.29

508.60

mg/l

0.47

171

1245

Corneal ulcer

565

1.10

0.28

1.1

1.0

303.16

284.74

mg/l

0.95

512

Bursitis of shoulder

1.27

0.27

1.0

339.50

280.65

mg/l

—

Primary gonarthrosis, bilateral

133

1236

0.94

0.27

1.1

283.77

292.28

mg/l

0.80

108

1100

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

107

1000

1.07

0.27

1.0

1.1

292.73

284.14

mg/l

0.52

903

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

206

1602

1.05

0.27

1.1

302.74

485.19

mg/l

0.49

185

1433

Maternal care for known or suspected abnormality of pelvic organs

569

1.08

0.27

1.1

308.35

309.71

mg/l

0.05

512

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

1.20

0.26

1.0

304.88

275.34

mg/l

—

Exposure to other and unspecified animate mechanical forces

1.30

0.26

1.0

1.1

252.50

296.38

mg/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.30

0.26

1.2

1.0

293.20

289.57

mg/l

—

L02BG Aromatase inhibitors

749

0.92

0.26

1.1

1.0

304.29

299.54

mg/l

0.27

653

Dementia

532

0.92

0.26

1.0

294.61

291.26

mg/l

0.14

467

Glucosamine medication

121

1026

0.94

0.25

1.1

1.0

299.25

293.26

mg/l

0.48

102

902

Multiple gestation

266

0.86

0.24

1.0

1.1

281.52

303.98

mg/l

1.22

239

Coxarthrosis, primary

155

1416

0.95

0.24

1.1

295.21

290.84

mg/l

0.29

137

1250

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

137

0.80

0.24

1.1

1.0

278.36

297.02

mg/l

0.93

121

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

416

0.90

0.24

1.1

1.0

310.71

299.51

mg/l

0.50

368

Schizotypal disorder

1.29

0.24

1.0

1.1

294.20

285.44

mg/l

—

Sudden idiopathic hearing loss

255

1.14

0.24

1.1

1.0

300.21

289.79

mg/l

0.27

228

Dementia, including avohilmo

578

0.93

0.23

1.0

294.87

290.64

mg/l

0.19

506

Other disorders of penis

294

1.12

0.23

1.0

1.1

271.48

277.42

mg/l

0.21

271

Adhesive middle ear disease

1.28

0.23

1.0

1.1

282.40

273.44

mg/l

—

Left bundle-branch block

153

1.18

0.22

1.0

289.39

281.05

mg/l

0.25

137

Fracture of forearm

174

1703

0.96

0.22

1.0

1.1

296.09

466.91

mg/l

0.48

162

1510

Lymphoid leukaemia

116

1.21

0.22

1.0

299.33

286.37

mg/l

—

103

Intussusception

1.19

0.21

1.4

1.1

303.60

285.11

mg/l

—

Adrenogenital disorders

0.00

0.21

0.0

1.1

—

285.30

—

Strabismus

835

1.06

0.21

1.0

1.1

288.87

287.00

mg/l

0.09

752

Atrial septal defect

100

0.79

0.21

1.0

1.1

350.38

291.97

mg/l

—

Herpesviral keratitis and keratoconjunctivitis

102

0.78

0.21

1.1

1.0

325.63

286.26

mg/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

899

1.06

0.21

1.1

308.89

303.35

mg/l

0.37

800

Spontaneous abortion

159

1033

1.05

0.21

1.1

2186.45

300.61

mg/l

0.50

142

917

Other and unspecified disorders of vitreous body

117

1105

1.05

0.20

1.1

1.0

295.54

292.66

mg/l

0.19

100

982

Family history of certain disabilities and chronic diseases leading to disablement

123

0.81

0.20

1.1

1.0

287.20

295.38

mg/l

—

112

Hallux rigidus

364

1.10

0.20

1.1

283.94

294.13

mg/l

0.50

324

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.20

0.0

1.0

—

311.86

—

Chronic iridocyclitis

136

1.18

0.20

1.2

1.0

272.56

290.03

mg/l

0.92

119

Supervision of normal pregnancy

423

1.07

0.20

1.1

295.25

316.47

mg/l

1.73

387

Superficial injury of neck

1.18

0.19

1.0

315.83

289.33

mg/l

—

Twin gestation

260

0.88

0.19

1.0

1.1

281.52

304.84

mg/l

1.28

233

Basal cell carcinoma, including avohilmo

148

1115

1.05

0.19

1.1

1.0

309.43

290.41

mg/l

2.41

123

990

Later onset COPD

368

0.92

0.19

1.0

306.94

285.97

mg/l

0.94

319

Lymphoid leukaemia

118

1.19

0.19

1.0

299.33

284.30

mg/l

—

105

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

175

0.86

0.19

1.1

1.0

303.73

290.58

mg/l

0.25

155

Carcinoma in situ of other and unspecified digestive organs

1.13

0.18

1.0

279.33

286.00

mg/l

—

Hallux valgus (acquired)

111

764

1.05

0.18

1.1

309.56

688.03

mg/l

0.48

680

Any dementia, excluding more controls

389

0.93

0.18

1.0

290.18

296.74

mg/l

0.25

343

Other hammer toe(s) (acquired)

398

1.08

0.18

1.1

311.42

297.89

mg/l

0.58

350

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.19

0.18

1.1

1.0

242.57

265.96

mg/l

—

Other benign neoplasms of connective and other soft tissue

271

1.11

0.18

1.1

1.0

314.13

293.12

mg/l

0.51

248

Other strabismus

706

1.06

0.17

1.0

1.1

294.69

287.79

mg/l

0.37

643

Burn and corrosion of head and neck

0.73

0.17

1.0

359.60

285.47

mg/l

—

Mandibular retrognathia

204

0.88

0.16

1.0

294.33

292.27

mg/l

0.02

189

Mandibular retrognathia AND surgery (BSSRO)

0.71

0.16

1.0

1.1

267.20

286.28

mg/l

—

Postpartum haemorrhage

719

1.05

0.16

1.0

1.1

302.18

306.57

mg/l

0.21

648

Pneumonia due to other infectious organisms, not elsewhere classified

1.11

0.16

1.1

1.0

328.63

283.08

mg/l

—

Non-Hodgkin lymphoma, all

1.11

0.16

1.0

302.38

294.54

mg/l

—

Bacterial pneumoniae

119

1010

1.04

0.15

1.1

1.0

293.08

285.13

mg/l

0.60

113

901

Postprocedural disorders of digestive system, not elsewhere classified

1.10

0.15

1.0

271.75

280.89

mg/l

—

IgA nephropathy (IgA glomerulonephritis)

0.78

0.15

1.2

1.0

243.33

277.23

mg/l

—

Burn and corrosion of trunk

0.78

0.15

1.2

1.0

250.50

289.16

mg/l

—

Polyp of the female genital tract

544

1.05

0.15

1.0

1.1

293.10

853.00

mg/l

0.51

484

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

456

0.95

0.15

1.0

1.1

281.34

275.17

mg/l

0.34

416

Other erythematous conditions

1.11

0.15

1.0

282.22

287.43

mg/l

—

Injury of muscle and tendon at lower leg level

439

1.07

0.15

1.1

280.52

283.08

mg/l

0.07

396

Sequelae of infectious and parasitic diseases

213

0.89

0.15

1.0

1.1

292.68

280.66

mg/l

0.30

193

Status post-ami

0.80

0.14

1.0

314.14

294.10

mg/l

—

Hodgkin lymphoma

1.09

0.14

1.2

1.0

331.78

282.62

mg/l

—

Congenital malformations of the circulatory system

435

1.07

0.14

1.0

1.1

302.02

285.49

mg/l

0.55

397

Sequelae of injuries of neck and trunk

1.18

0.14

1.3

1.0

318.91

279.19

mg/l

0.68

Poor fetal growth

337

0.92

0.14

1.0

1.1

287.68

302.70

mg/l

0.66

308

Benign lipomatous neoplasm

821

1.05

0.14

1.0

1.1

289.62

286.51

mg/l

0.16

736

Coronary revascularization (ANGIO or CABG)

126

848

1.04

0.13

1.0

1.1

291.73

283.66

mg/l

0.53

116

755

Other and unspecified iridocyclitis

109

0.82

0.13

1.0

282.33

284.31

mg/l

—

Postpartum haemorrhage due to retained placenta

386

0.93

0.12

1.1

307.67

298.17

mg/l

0.23

361

Basal cell carcinoma

142

1096

1.03

0.12

1.1

1.0

307.54

290.38

mg/l

2.03

118

973

Other fall from one level to another

708

1.04

0.12

1.0

1.1

282.72

283.23

mg/l

0.02

642

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

141

938

1.03

0.11

1.1

1.0

302.66

287.82

mg/l

1.61

121

844

Benign neoplasm: Skin of eyelid, including canthus

376

1.06

0.11

1.1

1.0

300.36

292.25

mg/l

0.28

336

Dermatitis due to ingested food

101

1.15

0.11

1.0

1.1

260.83

287.55

mg/l

0.86

Maternal care for other known or suspected fetal problems

499

1.04

0.11

1.0

1.1

292.32

313.54

mg/l

2.83

450

Bacterial pneumonia (organism specified)

126

1113

1.03

0.11

1.1

296.55

286.40

mg/l

0.83

119

992

Hyperplasia of prostate

112

618

1.03

0.10

1.1

1.0

271.77

277.48

mg/l

0.38

572

Malignant neoplasm of skin

166

1218

1.03

0.10

1.1

302.15

290.82

mg/l

1.23

139

1084

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

1.15

0.10

1.0

316.18

289.63

mg/l

0.53

Toxic effect of contact with venomous animals

106

1.13

0.09

1.1

1.0

301.17

284.97

mg/l

0.47

Injuries to the hip and thigh

129

1149

1.03

0.09

1.1

298.96

285.88

mg/l

0.94

114

1025

Maxillary retrognathism

1.04

0.09

1.2

1.0

251.60

301.14

mg/l

—

Disorders of breast

159

1440

1.02

0.09

1.1

302.90

512.94

mg/l

0.50

143

1276

Viral haemorrhagic fevers, not elsewhere classified/unspecified

223

1.08

0.09

1.2

1.1

272.75

286.48

mg/l

0.38

206

False labour

109

665

1.03

0.09

1.0

1.1

294.98

309.26

mg/l

1.18

103

604

Alopecia areata

1.11

0.09

1.0

285.50

298.27

mg/l

—

Sequelae of other external causes

134

0.89

0.08

1.2

1.0

304.17

291.80

mg/l

0.34

121

Carcinoma in situ of other and unspecified digestive organs

1.07

0.08

1.0

279.33

290.68

mg/l

—

1.02

0.08

1.0

1.1

247.00

281.89

mg/l

—

Dissocial personality disorder

0.80

0.08

1.0

1.1

284.20

262.89

mg/l

—

Patellar tendinitis

0.81

0.08

1.2

1.1

300.60

277.41

mg/l

—

Burns and corrosions of multiple and unspecified body regions

0.78

0.08

1.0

271.40

280.80

mg/l

—

Injury of nerves and spinal cord at neck level

1.09

0.08

1.1

1.0

273.00

284.42

mg/l

—

Other benign neoplasms of connective and other soft tissue

283

1.06

0.08

1.1

1.0

314.13

291.00

mg/l

0.58

255

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

504

0.97

0.08

1.0

1.1

278.29

272.93

mg/l

0.31

460

Other surgical follow-up care

1.05

0.08

1.1

1.0

281.86

277.80

mg/l

—

Unspecified lump in breast

409

0.95

0.08

1.2

1.0

304.41

297.53

mg/l

0.31

359

Other, unspecified and serous retinal detachments

1.03

0.08

1.1

1.0

273.43

279.43

mg/l

—

Exposure to smoke, fire and flames

0.86

0.07

1.0

253.83

280.76

mg/l

—

Lesion of sciatic nerve

0.84

0.07

1.0

245.83

296.51

mg/l

—

Peripheral retinal degeneration

0.80

0.07

1.0

288.33

284.42

mg/l

—

Disorders of eyelid in diseases classified elsewhere

0.80

0.07

1.2

1.1

263.67

289.22

mg/l

—

Other and unspecified corneal deformities and disorders

1.04

0.07

1.1

1.0

287.25

283.73

mg/l

—

Major anomalies of jaw size

0.85

0.07

1.1

1.0

290.29

284.68

mg/l

—

Hodgkin lymphoma, hilmo

1.05

0.07

1.2

1.0

331.78

283.99

mg/l

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

164

1597

1.02

0.07

1.0

1.1

288.03

290.23

mg/l

0.14

146

1440

Benign neoplasm: Skin of eyelid, including canthus

383

1.04

0.07

1.1

1.0

300.36

289.32

mg/l

0.41

344

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

1.12

0.07

1.2

1.0

257.30

274.88

mg/l

—

Other disorders involving the immune mechanism, not elsewhere classified

1.12

0.07

1.2

1.0

257.30

274.87

mg/l

—

Neovascular glaucoma

0.89

0.06

1.0

314.50

288.38

mg/l

—

Blepharochalasis

730

1.03

0.06

1.1

286.80

295.70

mg/l

0.53

650

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

217

1.06

0.06

1.0

284.88

293.06

mg/l

0.26

198

LeFortI or BSSRO operation

121

0.91

0.06

1.0

1.1

263.45

288.88

mg/l

2.04

112

Transient ischemic attack

133

1122

0.98

0.06

1.0

287.33

292.13

mg/l

0.36

119

997

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

932

1.02

0.05

1.1

289.05

279.37

mg/l

0.62

846

Malignant melanoma

357

1.04

0.04

1.1

1.0

290.03

289.41

mg/l

0.02

317

Complications of labour and delivery

221

1246

0.99

0.04

1.1

297.32

546.09

mg/l

0.52

202

1108

Preparation and fitting of bite rail to mouth

427

1.03

0.04

1.0

289.13

289.12

mg/l

0.00

389

Recurrent dislocation and subluxation of joint

229

1.05

0.04

1.1

285.04

284.67

mg/l

0.01

203

Sequelae of other and unspecified infectious and parasitic diseases

180

0.94

0.04

1.0

1.1

293.76

279.63

mg/l

0.32

164

Other disorders of ear

337

2228

1.01

0.04

1.1

291.60

422.68

mg/l

0.49

302

2006

Other specified/unspecified hearing loss

190

0.95

0.04

1.0

282.17

290.80

mg/l

0.26

169

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

119

0.92

0.04

1.2

1.0

290.91

279.83

mg/l

0.20

109

Malignant neoplasm of breast, HER-negative

497

1.03

0.03

1.1

312.95

299.93

mg/l

0.70

436

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

220

1.05

0.03

1.0

284.88

288.97

mg/l

0.12

197

Tinnitus

667

1.02

0.03

1.1

1.0

287.28

289.19

mg/l

0.07

600

Persons with potential health hazards related to communicable diseases

137

1373

0.99

0.03

1.1

294.23

288.36

mg/l

0.30

127

1250

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

127

886

0.99

0.03

1.1

1.0

304.33

287.94

mg/l

1.70

106

795

Fracture of femur

474

1.02

0.02

1.1

1.0

306.91

285.01

mg/l

1.49

415

Other disorders of eyelid

113

1104

0.99

0.02

1.1

1.0

285.29

294.21

mg/l

0.76

101

984

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

577

0.98

0.02

1.1

1.0

310.73

296.78

mg/l

0.85

511

Preterm labour and delivery

841

0.99

0.02

1.1

305.41

304.91

mg/l

0.02

737

Deep bite

307

1.03

0.02

1.1

280.77

290.66

mg/l

0.33

281

Atopic conjunctivitis

107

0.93

0.02

1.0

1.1

273.10

295.16

mg/l

—

Separation of retinal layers (serosa)

113

1.06

0.02

1.2

1.1

285.50

281.19

mg/l

0.08

101

Coronary angioplasty

698

0.99

0.01

1.0

1.1

292.70

283.20

mg/l

0.58

617

Cardiac murmurs and other cardiac sounds

254

0.97

0.01

1.1

292.94

291.28

mg/l

0.03

231

Carcinoma in situ of cervix uteri

234

1.03

0.00

1.1

1.0

319.33

298.62

mg/l

0.80

213

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

160

1097

1.00

0.00

1.1

1.0

297.45

287.80

mg/l

0.94

139

983

Benign lipomatous neoplasm

862

1.00

0.00

1.0

289.62

288.53

mg/l

0.05

773

Glaucoma suspect

921

1.00

0.00

1.0

1.1

295.56

291.07

mg/l

0.27

826

Bacterial pneumonia, not elsewhere classified

107

951

1.00

0.00

1.0

293.99

284.85

mg/l

0.66

102

847

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

112

979

1.00

0.00

1.1

303.80

286.85

mg/l

1.69

879

TMD related operations

534

0.99

0.00

1.0

1.1

291.29

288.58

mg/l

0.07

488

Fracture of neck

151

0.99

0.00

1.0

284.53

282.94

mg/l

0.03

140

Gonarthrosis,primary

307

1933

1.00

0.00

1.1

288.28

443.95

mg/l

0.51

261

1742

Schizophrenia

555

1.01

0.00

1.1

289.96

282.27

mg/l

0.33

508

HSIL lesion of the cervix uteri, vagina or vulva

595

1.01

0.00

1.1

309.82

298.94

mg/l

0.59

535

Other and/or unspecified nontoxic goitre

176

1.02

0.00

1.1

1.0

290.44

300.97

mg/l

0.29

157

Artificial joint operation, meniscal resection

323

2147

1.00

0.00

1.1

281.27

429.27

mg/l

0.55

282

1924

Malignant neoplasm of eye, brain and central nervous system

109

1.01

0.00

1.2

1.0

320.18

282.55

mg/l

0.68

Carcinoma in situ of cervix uteri

239

1.00

0.00

1.1

1.0

319.33

298.64

mg/l

0.80

216

Intermittent heterotropia

148

1.01

0.00

1.0

1.1

249.60

297.06

mg/l

2.34

131

Inflammatory disease of uterus

391

1.00

0.00

1.1

1.0

318.85

301.58

mg/l

0.73

348

Emergency coronary revascularization (for ACS)

135

966

1.00

0.00

1.0

1.1

290.65

284.38

mg/l

0.41

124

859

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

267

1.01

0.00

1.1

287.81

285.67

mg/l

0.05

238

Glaucoma-related operations

107

1.03

0.00

1.0

298.64

292.58

mg/l

0.17

Maternal care for known or suspected disproportion

127

1.02

0.00

1.1

1.0

280.69

309.88

mg/l

0.61

113

Arthropod-borne viral fevers and viral haemorrhagic fevers

273

0.99

0.00

1.2

1.1

267.30

288.37

mg/l

0.74

251

Other and unspecified abdominal hernia

1.05

0.00

1.0

316.70

284.19

mg/l

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

132

907

1.00

0.00

1.1

1.0

306.76

288.40

mg/l

2.01

110

816

Noonan syndrome

0.00

0.0

1.2

—

280.00

—

Bilateral sagittal split ramus osteotomy operation

0.93

0.00

1.0

1.1

266.67

285.89

mg/l

—

Assault by other and unspecified firearm discharge

0.00

0.0

1.0

—

251.67

—

Viral conjunctivitis

0.93

0.00

1.2

1.1

302.00

286.67

mg/l

—

Contact with lifting and transmission devices, not elsewhere classified

0.95

0.00

1.0

279.50

271.02

mg/l

—

Polyglandular dysfunction

0.00

0.0

1.0

—

282.20

—

Correction of physiology of bite - very demanding therapy visit

0.88

0.00

1.0

1.1

294.00

299.45

mg/l

—

Pedestrian injured in collision with pedal cycle

0.92

0.00

1.0

292.62

287.55

mg/l

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.02

0.00

1.0

1.1

255.80

275.64

mg/l

—

Other and unspecified erythematous conditions

1.00

0.00

1.0

1.1

302.14

290.17

mg/l

—

Sixth [abducent] nerve palsy

0.95

0.00

1.0

254.00

292.60

mg/l

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.0

1.2

—

274.80

—

Benign neoplasm: Renal pelvis

0.00

0.0

1.2

—

239.60

—

Open wound of shoulder and upper arm

0.85

0.00

1.0

298.60

274.70

mg/l

—

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.88

0.00

1.0

322.20

278.56

mg/l

—

Other sideroblastic anaemias

0.00

0.0

1.2

—

278.50

—

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

293.71

—

Disorders of amino-acid transport

0.00

0.0

1.0

—

315.20

—

Other specified disorders of muscle

0.96

0.00

1.1

1.0

254.00

274.78

mg/l

—

Other specified and unspecified disorders of eye and adnexa

0.93

0.00

1.1

1.0

321.33

287.79

mg/l

—

Benign neoplasm: Renal pelvis

0.00

0.0

1.2

—

221.33

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.93

0.00

1.0

322.20

277.91

mg/l

—

Thromboangiitis obliterans

0.00

0.0

1.1

—

265.43

—

Traumatic spondylopathy

0.00

0.0

1.0

—

285.60

—

Other diseases of spinal cord

0.93

0.00

1.0

276.13

285.26

mg/l

—

Inguinal hernia, unilateral

0.85

0.00

1.0

323.80

286.14

mg/l

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

0.0

1.0

—

267.33

—

Femoral hernia, unilateral

0.85

0.00

1.0

323.80

286.14

mg/l

—

Disorder of visual pathways, unspecified

0.00

0.0

1.2

—

286.20

—

Malignant neoplasm of thymus

0.00

0.0

1.1

—

304.00

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.0

1.0

—

280.83

—

Malignant neoplasm of brain

0.92

0.00

1.3

1.0

300.75

283.02

mg/l

—

Eccrine sweat disorders

0.00

0.0

1.0

—

308.60

—

Corneal scars and opacities

0.92

0.00

1.2

1.0

302.00

286.60

mg/l

—

Rheumatic heart disease, other

0.00

0.0

1.2

—

280.83

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.0

1.0

—

241.40

—

Glaucoma secondary to other eye disorders

0.98

0.00

1.0

308.33

291.35

mg/l

—

Myeloid leukaemia

1.00

0.00

1.2

1.0

326.17

274.64

mg/l

—

Benign neoplasm: Pineal gland

0.00

0.0

1.1

—

282.29

—

Primary angle-closure glaucoma

0.90

0.00

1.1

1.0

300.88

301.41

mg/l

—

Problems related to social environment

0.85

0.00

1.2

1.1

53385.20

295.54

mg/l

—

Myeloid leukaemia

0.98

0.00

1.2

1.0

326.17

285.45

mg/l

—

Inguinal of femoral hernia, unilateral

0.85

0.00

1.0

323.80

286.14

mg/l

—

Degenerative conditions of globe

0.00

0.0

1.0

—

257.20

—

Injury of muscle and tendon at ankle and foot level

0.96

0.00

1.0

272.29

286.88

mg/l

—

Other congenital malformations of face and neck

0.93

0.00

1.1

1.0

295.25

287.91

mg/l

—

Ectropion of eyelid

0.89

0.00

1.0

283.40

294.53

mg/l

—

Congenital malformations of nose

0.00

0.0

1.2

—

285.40

—

Sacrococcygeal disorders, not elsewhere classified

1.00

0.00

1.1

295.57

285.77

mg/l

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

0.0

1.2

—

294.50

—

Exposure to sunlight

0.00

0.0

1.0

—

286.00

—

Other specified/unspecified spondylopathies

0.96

0.00

1.0

280.40

275.59

mg/l

—

Osteogenesis imperfecta

0.00

0.0

1.2

—

294.60

—

Other and unspecified disorders of globe

0.00

-0.00

0.0

1.2

—

255.60

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ceruloplasmin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS